Streptomyces djakartensis NW35菌株发酵液的抑菌活性及抑菌成分研究
|
摘要
放线菌是一类重要的微生物资源，它是抗生素及其他生物活性物质的主要生产者，其中又以链霉菌属产生的最多。随着大量具有生物活性菌株被分离，再用传统的筛选思路往往造成重复研究，从中发现新生物活性化合物的几率也越来越低，所以寻找稀有放线菌进一步发现新的活性物质成为科学研究的重要方向。
本论文以从农药污染源土壤中分离到的放线菌NW35菌株为研究对象，系统研究该菌株的分类地位、发酵液抑菌活性、发酵液中活性成分的分离鉴定。此外，还对作用机理及发酵条件优化进行了初步研究。主要研究结果如下：
1.形态特征和培养特征观察、生理生化特性测定和16S rDNA序列分析的结果表明，NW35菌株与模式菌株Streptomyces djakartensis NBRC15409的同源相似性为99%，NW35菌株除在葡萄糖天冬酰胺琼脂培养基上的培养特征，在马铃薯块上的生长情况、明胶液化、淀粉水解这些指标与模式菌株略不相同外，NW35菌株与模式菌株其他指标大体一致。因此采用多相分类法，将NW35菌株鉴定为Streptomyces djakartensis NW35。该菌株已在中国微生物菌种保藏管理委员会普通微生物中心保藏，保藏日期为2012年11月13日，保藏登记号为CGMCC No.6817。
2.测定了NW35菌株发酵液的抑菌活性。离体活性生测结果表明，NW35菌株发酵液对供试9种细菌和8种植物病原真菌都有一定的抑制作用。发酵液对革兰氏阳性细菌蜡状芽孢杆菌、枯草芽孢杆菌、金黄色葡萄球菌、耐甲氧西林金黄色葡萄球菌有较强的抑制作用，抑菌圈透明；对革兰氏阴性细菌大肠埃氏菌、铜绿假单胞菌、白菜软腐病菌、猕猴桃溃疡病菌、青枯病病菌也有一定的抑制作用，但抑菌圈透明度较差。发酵液对供试植物病原真菌的抑制作用较弱，只对油菜菌核病菌的菌丝生长抑制率达到73.68%，其余都在70%以下。盆栽试验结果表明，菌株发酵液对小麦白粉病的保护和治疗作用都较差，分别为41.89%和38.41%。
3.采用活性追踪法，将NW35菌株发酵液通过HPD100大孔吸附树脂富集、硅胶柱层析和反相高效液相色谱制备，分离到4个化合物。根据波谱数据分析确定了它们的化学结构和立体构型，其中3个为新化合物，分别为(E)-2-甲氧基-1,4萘醌-1-肟（Z-4-1）、(R)-2-羟甲基-3,4-二氢-1,4-苯并氮氧杂卓-5(1H)酮（Z-4-2）及2-(2-羟基-1-羟甲基-乙氨基)苯甲酸（Z-8-2）；1个已知化合物，即N-乙酰色胺（Z-9-2）。其中化合物Z-4-2为发酵液的主要抑菌活性成分，为一新抗生素，命名为西农霉素(Xinongmycin)，并申请了国家发明专利（专利申请号：201310028444.1）。
采用微量稀释法，测得西农霉素对革兰氏阳性细菌和革兰氏阴性细菌均有较强的抑制作用，对猕猴桃溃疡病菌的最小抑菌浓度(MIC)为7.81μg/mL，对蜡状芽孢杆菌、枯草芽孢杆菌、金黄色葡萄球菌、耐甲氧西林金黄色葡萄球菌、青枯病病菌最小抑菌浓度均为15.63μg/mL，对大肠埃氏菌、铜绿假单胞菌、白菜软腐病菌的最小抑菌浓度为31.25μg/mL，比阳性对照氨苄青霉素抑菌活性强。西农霉素对4种植物病原真菌的孢子萌发都有一定的抑制作用，当浓度为500μg/mL时，对棉花枯萎病菌、玉米弯孢叶斑病菌、黄瓜炭疽病菌的孢子萌发抑制率均在90%以上。Z-4-1、Z-9-2在剂量为10μg/纸碟时对蜡状芽孢杆菌、枯草芽孢杆菌、金黄色葡萄球菌、大肠埃氏细菌、猕猴桃溃疡病菌、青枯病病菌、耐甲氧西林金黄色葡萄球菌均有一定抑制作用，其中对蜡状芽孢杆菌和枯草芽孢杆菌有明显的抑制作用，抑菌圈透明。
4.初步研究了西农霉素对蜡状芽孢杆菌的作用机理。西农霉素以MIC浓度处理不同时间后细胞内还原糖、丙氨酸转氨酶（ALT）、天冬氨酸转氨酶（AST）都有泄露。经西农霉素处理后，和对照相比，细胞膜相对渗透率升高。这些结果说明西农霉素破坏了细胞膜。此外，蜡状芽孢杆菌经西农霉素处理后其细胞蛋白含量、琥珀酸脱氢酶（SDH）和苹果酸脱氢酶（MDH）活性均降低。结合扫描电镜症状学观察，初步认为西农霉素可能破坏细胞膜，改变细胞膜相对渗透率，抑制蛋白合成进而导致细胞代谢紊乱，最后细胞裂解死亡。
5.采用响应面分析法和正交试验设计，对菌株NW35发酵条件进行了优化，确定了最佳发酵培养基及最佳摇瓶发酵条件。最佳发酵培养基为：蔗糖10g/L，乳糖10g/L，麦芽糖10g/L，麦麸27.68g/L，蛋白胨4.5g/L，NH_4Cl3g/L，(NH_4)_2SO_43g/L，CaCO_30.87g/L、FeSO40.0073g/L。最佳发酵条件：250mL三角瓶装入60mL发酵培养基，接入6×10~7cfu/mL菌量，28℃培养144h。在最优培养基、最优发酵条件下对NW35菌株进行发酵培养，得到的西农霉素含量为12.86μg/mL，而原始发酵条件西农霉素含量仅为1.6021μg/mL，是原始含量的8.03倍。研究了前体添加对NW35菌株发酵液中西农霉素含量的影响。结果表明，无论是单一前体添加还是复合前体添加，均未显著提高NW35菌株发酵液中西农霉素的含量，但在添加0.5g/L缩水甘油实验中，HPLC谱图中出现了一个在原始发酵液中未曾出现的新的波谱峰。
Acyinomyces is one of the most important microorganism resources, which can produceantibiotics and other bioactive substances, the discovery of novel bioactive compounds isbecoming difficult with a large number of bioactive strain have been isolated by traditionaltactics. Exploration of rare actinomycete has become an important direction to discover newactive substance.
This paper is about the research work on the actinomycete strain NW35, which wasisolated from a pesticide-polluted soil, including strain identification, antimicrobial activity offermentation broth, purification and structural identification, mechanism and optimizationfermentation conditions. The primary results are as follows:
1. According to the results of morphological and culture characteristics, physiology andbiochemical measurement and16S rDNA sequence analysis, NW35strain was highlyhomological(up to99%) with Streptomyces djakartensis NBRC15409, except for culturecharacteristics on glucose asparagines agar and potato, gelatin liquefaction and starchhydrolysis properties. The NW35strain was identified and designated as Streptomycesdjakartensis NW35. The strain is deposited in the center of the China GeneralMicrobiological Culture Collection Center, November13,2012, with the registration numberof CGMCC No.6817.
2. The antimicrobial activity of fermentation broth from strain NW35was tested.Bioassay results in vitro showed that the fermentation broth exhibited different antimicrobialactivity against9species of tested bacteria and8species of tested plant pathogens. Thefermentation broth had strong inhibition against Bacillus cereus, Bacillus subtilis,Staphylococcus aureus, methicillin-resistant Staphylococcus aureus with transparentinhibition zone, and inhibition against Escherichia coil, Pseudomonas aeruginosa, Erwiniacarotovora, Pseudomonas syringae pv.actinidiae, Ralstonia solanacearum with clearinhibition zone. The fermentation broth possessed good inhibition against Sclerotiniasclerotiorum(73.68%) and certain degree inhibition against the other tested plant pathogens,The protective efficacy and curative efficacy of the fermentation broth against Blumeria giamiais were41.89%and38.41%, respectively.
3.Four compounds have been separated through bioassay guided fraction, includingenrichment by HPD100macroporous resin, and separation on silica gel column chroma-tography and preparation reversed-phase high performance liquid chromatography. Accordingto spectroscopy datas, the separated four compounds have been elucidated as:(E)-2-methoxy1-4-naphthoquinone1-oxime(Z-4-1),2-(hydroxymethyl)-2,3-dihydrobenzo[e][1,4]oxazepin-5-(1H)-one(Z-4-2),2-(2-Hydroxy-1-hydroxymethyl-ethylamino)-benzoic acid (Z-8-2) arenovel compounds. N-Acetyl-tryptamine (Z-9-2) are known compounds. Compound Z-4-2isthe main bacteriostatic active ingredients of the fermentation broth, which is a new antibiotic,and named as Xinongmycin.
According to microdilution method, the bioassay results in vitro showed that Xinongmycinexhibited antibacterial activity against Pseudomonas syringae pv.actinidiae with MIC valuesof7.8μg/mL, Bacillus cereus, Bacillus subtilis, Staphylococcus aureus, methicillin-resistantStaphylococcus aureus, Ralstonia solanacearum with MIC values of15.6μg/mL, Escherichiacoil, Pseudomonas aeruginosa, Erwinia carotovora with MIC values of31.3μg/mL. Sporegermination demonstrated Xinongmycin showed strong inhibition against Fusariumoxysporum f.sp.vasinfectum, Curvularia lunata, Colletotrichum orbiculare, Colletotrichumgloesporioides, with the inhibition rate of above90%at the concentration of500μg/mL.Z-4-1，Z-9-2also showed certain degree antibiotic activity against Bacillus cereus, Bacillussubtilis, Erwinia carotovora, Staphylococcus aureus, Escherichia coil, Pseudomonasaeruginosa, methicillin-resistant Staphylococcus aureus, Pseudomonas syringae pv. actinidiae,Ralstonia solanacearum.
4. The preliminary mechanism of Xinongmycin against Bacillus cereus was investigated.When the bacteria was treated with Xinongmycin at MIC with different time, the releasementof reducing sugar, alanine aminotransferase(ALT), and aspartate aminotransferase (AST)were detected and the relative permeability of cell membrane was higher than control.Together with scanning electron microscopy, further detection of the decrement, in activitiesof of succinate dehydrogenase (SDH) and malate dehydrogenase (MDH) demonstratedXinongmycin might damage the cell membrane, enhance the cell membrane relativepermeability, and inhibit protein synthesis leading to cell metabolism disorder and cell deathfinally.
5. The optimized fermentation for strain NW35was obtained by response surfacemethodology and the orthogonal experiment design. The best formula is: sucrose10g/L,lactose,10g/L, maltose,10g/L, wheat bran,27.68g/L, peptone4.5g/L, NH_4Cl3g/L and (NH_4)_2SO_43g/L, CaCO_3,0.87g/L, FeSO40.0073g/L. Best fermentation condition:60mLmedium in250mL flask,6×10~7cfu/mL bacteria amount,28℃,144h. In the optimal culturemedium and fermentation conditions, the content of Xinongmycin(12.86μg/mL) is8.03timesof the original content(1.60μg/mL). The influence of feeding precursor on the production ofXinongmycin showed that neither single precursor nor composite precursor can significantlyimprove the content of Xinongmycin.
本论文以从农药污染源土壤中分离到的放线菌NW35菌株为研究对象，系统研究该菌株的分类地位、发酵液抑菌活性、发酵液中活性成分的分离鉴定。此外，还对作用机理及发酵条件优化进行了初步研究。主要研究结果如下：
1.形态特征和培养特征观察、生理生化特性测定和16S rDNA序列分析的结果表明，NW35菌株与模式菌株Streptomyces djakartensis NBRC15409的同源相似性为99%，NW35菌株除在葡萄糖天冬酰胺琼脂培养基上的培养特征，在马铃薯块上的生长情况、明胶液化、淀粉水解这些指标与模式菌株略不相同外，NW35菌株与模式菌株其他指标大体一致。因此采用多相分类法，将NW35菌株鉴定为Streptomyces djakartensis NW35。该菌株已在中国微生物菌种保藏管理委员会普通微生物中心保藏，保藏日期为2012年11月13日，保藏登记号为CGMCC No.6817。
2.测定了NW35菌株发酵液的抑菌活性。离体活性生测结果表明，NW35菌株发酵液对供试9种细菌和8种植物病原真菌都有一定的抑制作用。发酵液对革兰氏阳性细菌蜡状芽孢杆菌、枯草芽孢杆菌、金黄色葡萄球菌、耐甲氧西林金黄色葡萄球菌有较强的抑制作用，抑菌圈透明；对革兰氏阴性细菌大肠埃氏菌、铜绿假单胞菌、白菜软腐病菌、猕猴桃溃疡病菌、青枯病病菌也有一定的抑制作用，但抑菌圈透明度较差。发酵液对供试植物病原真菌的抑制作用较弱，只对油菜菌核病菌的菌丝生长抑制率达到73.68%，其余都在70%以下。盆栽试验结果表明，菌株发酵液对小麦白粉病的保护和治疗作用都较差，分别为41.89%和38.41%。
3.采用活性追踪法，将NW35菌株发酵液通过HPD100大孔吸附树脂富集、硅胶柱层析和反相高效液相色谱制备，分离到4个化合物。根据波谱数据分析确定了它们的化学结构和立体构型，其中3个为新化合物，分别为(E)-2-甲氧基-1,4萘醌-1-肟（Z-4-1）、(R)-2-羟甲基-3,4-二氢-1,4-苯并氮氧杂卓-5(1H)酮（Z-4-2）及2-(2-羟基-1-羟甲基-乙氨基)苯甲酸（Z-8-2）；1个已知化合物，即N-乙酰色胺（Z-9-2）。其中化合物Z-4-2为发酵液的主要抑菌活性成分，为一新抗生素，命名为西农霉素(Xinongmycin)，并申请了国家发明专利（专利申请号：201310028444.1）。
采用微量稀释法，测得西农霉素对革兰氏阳性细菌和革兰氏阴性细菌均有较强的抑制作用，对猕猴桃溃疡病菌的最小抑菌浓度(MIC)为7.81μg/mL，对蜡状芽孢杆菌、枯草芽孢杆菌、金黄色葡萄球菌、耐甲氧西林金黄色葡萄球菌、青枯病病菌最小抑菌浓度均为15.63μg/mL，对大肠埃氏菌、铜绿假单胞菌、白菜软腐病菌的最小抑菌浓度为31.25μg/mL，比阳性对照氨苄青霉素抑菌活性强。西农霉素对4种植物病原真菌的孢子萌发都有一定的抑制作用，当浓度为500μg/mL时，对棉花枯萎病菌、玉米弯孢叶斑病菌、黄瓜炭疽病菌的孢子萌发抑制率均在90%以上。Z-4-1、Z-9-2在剂量为10μg/纸碟时对蜡状芽孢杆菌、枯草芽孢杆菌、金黄色葡萄球菌、大肠埃氏细菌、猕猴桃溃疡病菌、青枯病病菌、耐甲氧西林金黄色葡萄球菌均有一定抑制作用，其中对蜡状芽孢杆菌和枯草芽孢杆菌有明显的抑制作用，抑菌圈透明。
4.初步研究了西农霉素对蜡状芽孢杆菌的作用机理。西农霉素以MIC浓度处理不同时间后细胞内还原糖、丙氨酸转氨酶（ALT）、天冬氨酸转氨酶（AST）都有泄露。经西农霉素处理后，和对照相比，细胞膜相对渗透率升高。这些结果说明西农霉素破坏了细胞膜。此外，蜡状芽孢杆菌经西农霉素处理后其细胞蛋白含量、琥珀酸脱氢酶（SDH）和苹果酸脱氢酶（MDH）活性均降低。结合扫描电镜症状学观察，初步认为西农霉素可能破坏细胞膜，改变细胞膜相对渗透率，抑制蛋白合成进而导致细胞代谢紊乱，最后细胞裂解死亡。
5.采用响应面分析法和正交试验设计，对菌株NW35发酵条件进行了优化，确定了最佳发酵培养基及最佳摇瓶发酵条件。最佳发酵培养基为：蔗糖10g/L，乳糖10g/L，麦芽糖10g/L，麦麸27.68g/L，蛋白胨4.5g/L，NH_4Cl3g/L，(NH_4)_2SO_43g/L，CaCO_30.87g/L、FeSO40.0073g/L。最佳发酵条件：250mL三角瓶装入60mL发酵培养基，接入6×10~7cfu/mL菌量，28℃培养144h。在最优培养基、最优发酵条件下对NW35菌株进行发酵培养，得到的西农霉素含量为12.86μg/mL，而原始发酵条件西农霉素含量仅为1.6021μg/mL，是原始含量的8.03倍。研究了前体添加对NW35菌株发酵液中西农霉素含量的影响。结果表明，无论是单一前体添加还是复合前体添加，均未显著提高NW35菌株发酵液中西农霉素的含量，但在添加0.5g/L缩水甘油实验中，HPLC谱图中出现了一个在原始发酵液中未曾出现的新的波谱峰。
Acyinomyces is one of the most important microorganism resources, which can produceantibiotics and other bioactive substances, the discovery of novel bioactive compounds isbecoming difficult with a large number of bioactive strain have been isolated by traditionaltactics. Exploration of rare actinomycete has become an important direction to discover newactive substance.
This paper is about the research work on the actinomycete strain NW35, which wasisolated from a pesticide-polluted soil, including strain identification, antimicrobial activity offermentation broth, purification and structural identification, mechanism and optimizationfermentation conditions. The primary results are as follows:
1. According to the results of morphological and culture characteristics, physiology andbiochemical measurement and16S rDNA sequence analysis, NW35strain was highlyhomological(up to99%) with Streptomyces djakartensis NBRC15409, except for culturecharacteristics on glucose asparagines agar and potato, gelatin liquefaction and starchhydrolysis properties. The NW35strain was identified and designated as Streptomycesdjakartensis NW35. The strain is deposited in the center of the China GeneralMicrobiological Culture Collection Center, November13,2012, with the registration numberof CGMCC No.6817.
2. The antimicrobial activity of fermentation broth from strain NW35was tested.Bioassay results in vitro showed that the fermentation broth exhibited different antimicrobialactivity against9species of tested bacteria and8species of tested plant pathogens. Thefermentation broth had strong inhibition against Bacillus cereus, Bacillus subtilis,Staphylococcus aureus, methicillin-resistant Staphylococcus aureus with transparentinhibition zone, and inhibition against Escherichia coil, Pseudomonas aeruginosa, Erwiniacarotovora, Pseudomonas syringae pv.actinidiae, Ralstonia solanacearum with clearinhibition zone. The fermentation broth possessed good inhibition against Sclerotiniasclerotiorum(73.68%) and certain degree inhibition against the other tested plant pathogens,The protective efficacy and curative efficacy of the fermentation broth against Blumeria giamiais were41.89%and38.41%, respectively.
3.Four compounds have been separated through bioassay guided fraction, includingenrichment by HPD100macroporous resin, and separation on silica gel column chroma-tography and preparation reversed-phase high performance liquid chromatography. Accordingto spectroscopy datas, the separated four compounds have been elucidated as:(E)-2-methoxy1-4-naphthoquinone1-oxime(Z-4-1),2-(hydroxymethyl)-2,3-dihydrobenzo[e][1,4]oxazepin-5-(1H)-one(Z-4-2),2-(2-Hydroxy-1-hydroxymethyl-ethylamino)-benzoic acid (Z-8-2) arenovel compounds. N-Acetyl-tryptamine (Z-9-2) are known compounds. Compound Z-4-2isthe main bacteriostatic active ingredients of the fermentation broth, which is a new antibiotic,and named as Xinongmycin.
According to microdilution method, the bioassay results in vitro showed that Xinongmycinexhibited antibacterial activity against Pseudomonas syringae pv.actinidiae with MIC valuesof7.8μg/mL, Bacillus cereus, Bacillus subtilis, Staphylococcus aureus, methicillin-resistantStaphylococcus aureus, Ralstonia solanacearum with MIC values of15.6μg/mL, Escherichiacoil, Pseudomonas aeruginosa, Erwinia carotovora with MIC values of31.3μg/mL. Sporegermination demonstrated Xinongmycin showed strong inhibition against Fusariumoxysporum f.sp.vasinfectum, Curvularia lunata, Colletotrichum orbiculare, Colletotrichumgloesporioides, with the inhibition rate of above90%at the concentration of500μg/mL.Z-4-1，Z-9-2also showed certain degree antibiotic activity against Bacillus cereus, Bacillussubtilis, Erwinia carotovora, Staphylococcus aureus, Escherichia coil, Pseudomonasaeruginosa, methicillin-resistant Staphylococcus aureus, Pseudomonas syringae pv. actinidiae,Ralstonia solanacearum.
4. The preliminary mechanism of Xinongmycin against Bacillus cereus was investigated.When the bacteria was treated with Xinongmycin at MIC with different time, the releasementof reducing sugar, alanine aminotransferase(ALT), and aspartate aminotransferase (AST)were detected and the relative permeability of cell membrane was higher than control.Together with scanning electron microscopy, further detection of the decrement, in activitiesof of succinate dehydrogenase (SDH) and malate dehydrogenase (MDH) demonstratedXinongmycin might damage the cell membrane, enhance the cell membrane relativepermeability, and inhibit protein synthesis leading to cell metabolism disorder and cell deathfinally.
5. The optimized fermentation for strain NW35was obtained by response surfacemethodology and the orthogonal experiment design. The best formula is: sucrose10g/L,lactose,10g/L, maltose,10g/L, wheat bran,27.68g/L, peptone4.5g/L, NH_4Cl3g/L and (NH_4)_2SO_43g/L, CaCO_3,0.87g/L, FeSO40.0073g/L. Best fermentation condition:60mLmedium in250mL flask,6×10~7cfu/mL bacteria amount,28℃,144h. In the optimal culturemedium and fermentation conditions, the content of Xinongmycin(12.86μg/mL) is8.03timesof the original content(1.60μg/mL). The influence of feeding precursor on the production ofXinongmycin showed that neither single precursor nor composite precursor can significantlyimprove the content of Xinongmycin.
引文
安德荣.2002.生物制药的原理及方法——抗生素制备北京:中国科学文化出版社.
操庆国,郭钦,黄敏和刘爱兰.2006.天然抗菌物质研究进展.保鲜与加工,34(3):10
曹亚.2003.实用分子生物学操作指南人民卫生出版社.
陈义光,李文均,崔晓龙,姜成林,徐丽华,张玉琴和文孟良.2006.具抗肿瘤活性放线菌菌株YIM90022的分离和系统发育分析.微生物学报,46(5):696-701
冯爱娟和彭春雷.2003.抗菌物质的研究进展.荆门职业技术学院学报,18(3):92-96
盖婷婷,宋学呜,钱秀萍和赵凤生.2005.株抗万古霉素耐药菌的抗生素产生菌ARl148的鉴定.工业微生物,35(3)
顾觉奋.2005.膜分离技术在微生物制药中的应用.中国抗生素杂志,30(1):26-31
顾觉奋和魏爱琳.2002.大孔网状吸附剂在微生物制药分离纯化上的应用.离子交换与吸附,18(3):281-288
侯慧,徐汉虹,林壁润和查友贵.2003.防治植物病害的农用抗生素的研究及应用.河南农业科学,11:28-31
黄惠娟和乔建军.2007.聚酮类抗生素组合生物合成.细胞生物学杂志,29(5):692-696
黄丽丽,康振生,韩青梅,王兰和宗兆锋.三唑酮对玉米弯孢病菌超微结构和细胞化学的影响.
黄秀梨.2000.微生物学实验指导北京:高等教育出版社.62～64
姜怡,段淑蓉,唐蜀昆,陈华红,李文均和徐丽华.2006.稀有放线菌分离方法.微生物学通报,33(1):181-183
蒋细良和谢德龄.1997.中生菌素的抗生作用.植物病理学报,27(2):133-138
焦瑞身.2004.新世纪微生物学者的一项重要任务——未培养微生物的分离培养.生物工程学报,20(5):641-645
康振生.1996.植物病原真菌的超微结构北京:中国科学技术出版.
李成云.1997.生物农药的安全性评价.云南农业科技(4):44-46
李春香,董占能和张召术.2001.离子交换树脂在天然产物提取分离中的应用.云南化工,28(5):26-28
梁世中.1995.生物分离技术华南理工大学出版社.
林璧润和杨丽梅.1998.管碟法测定抗生素2507的技术条件探讨.广东农业科学(2):38-40
刘春琴,高智慧,曹宇和白钢.2007.链霉菌ZG0429的分类鉴定与链霉亲和素的分离纯化研究.微生物学报,47(01):7-10
刘飞和伍小丽.2006.获取新抗生素的途径研究.重庆中草药研究(2):37-40
刘国诠.2003.生物工程下游技术化学工业出版社现代生物技术与医药科技出版中心.
刘进兵,林崇懒,万一千和宋化灿.2008.1,5-苯并二氮杂(艹卓)的合成及其生物活性研究Synthesis and Bioactivities of1,5-Benzodiazepine Derivatives.有機化學,28(2):317-320
刘姝,陆兆新,吕凤霞,别小妹,房耀维和丁重阳.2007.株海洋放线菌的分类鉴定及抗菌活性研究.南京农业大学学报,30(4):124-129
刘志恒和姜成林.2004.放线菌现代生物学与生物技术科学出版社.
刘志俊,谢德明和刘治波.2000.国外农药发展现状及未来展望.农药科学与管理,21(2):33-37
罗曼,蒋立科,王志强,奚俊和戴建勇.2003.山苍籽油及主要成份抗菌机制研究进展.微生物学通报,30(3):74-77
吕洪久.1991.化学功能材料.化工新型材料,（8）：43
毛忠贵.1999.生物工业下游技术中国轻工业出版社.
慕立义.1994.植物化学保护研究方法.北京:中国农业出版社,102-104
聂亚锋,刘永锋,李德全,陈志谊,刘邮洲和罗楚平.2008.海洋细菌PY-sw-1产生的抗菌物质及其抑菌活性.植物保护学报,35(4):373-374
彭云霞,姜怡,段淑蓉,李文均和徐丽华.2007.稀有放线菌的选择性分离方法[J].云南大学学报:自然科学版,29(1):86-89
钱存柔和黄仪秀.2008.微生物学实验教程北京:北京大学出版社.
屈良.1993.微生物系统发育的分子遗传学研究概述上海:复旦大学出版社.
沈寅初.1981.国内外农用抗生素研究和发展概况.抗生素,6(3):55-64
沈寅初.1996.井冈霉素研究开发25年.植物保护,22(4):44-45
盛龙生.2003.药物分析化学工业出版社.
施跃峰.2000.微生物杀虫剂研究进展.植物保护,26(5):32-34
孙秋,杨慧敏,褚红标,李铭刚和文孟良.2003.筛选新抗生素的方法.云南农业科技,4:43-45
孙峋,汪靖超,李洪涛,杜桂彩和郭道森.2005.迷迭香酸的抗菌机理研究.青岛大学学报(自然科学版),18(4):41-45
孙宇辉和邓子新.2006.聚酮化合物及其组合生物合成
唐经凡.2008.抗生素的作用机理及应用.中国现代药物应用,2(7):99-100
唐韵.2003.农用抗生素十问.农药市场信息,10:061
瓦克斯曼和阎逊初.1974.放线菌:属和种的分类,鉴定和描述.第二卷科学出版社.
汪茂田,谢培山和王忠东.2004.天然有机化合物提取分离与结构鉴定化学工业出版社.
王福来.2001.有机化学实验武汉:武汉大学出版社.
王广成,张忠明,高立明,陈丙坤,聂果,万莉和吴春先.2006.阿维菌素的作用机理及其应用现状[J].植物医生,19(1):4-5
王琦和梅汝鸿.2001.我国生物农药的发展现状.中国微生态学杂志,13(3):177-178
王湛和周翀.2006.膜分离技术基础化学工业出版社.
吴文君.1988.植物化学保护实验技术导论西安:陕西科学技术出版社.134-135
吴文君.1988.植物化学保护实验技术指导西安:西安：陕西科学技术出版社.
徐汉虹和安玉兴.2001.生物农药的发展动态与趋势展望.农药科学与管理,22(1):32-34
徐丽华,李文均和刘志恒等.2007.放线菌系统学—原理、方法及实践北京:科学出版社.41-44
徐明生,陈锦屏和上官新晨.2005.鱼精蛋白对黑曲霉细胞内的琥珀酸脱氢酶和苹果酸脱氢酶的影响.食品科学,26(4):48-50
徐铮,曹永兵和姜远英.2001.麦角甾醇生物合成途径中的抗真菌药作用靶酶.国外医药:抗生素分册,22(5):193-197
姚健.2000.农用化学品污染对土壤微生物群落DNA序列多样性影响研究.20（6）
姚汝华.1996.微生物工程工艺原理华南理工大学出版社.
姚新生.2001.天然药物化学.
余卿.1987.新抗生素的筛选.微生物学杂志,1:28
俞俊棠,唐孝宣,生物工艺学和邬行彦.2003.新编生物工艺学化学工业出版社教材出版中心.
俞文和和杨纪根.1988.抗生素工艺学辽宁科学技术出版社.
张继忠1990.微生物学分类.上海：复旦大学出版社:144-146
张丽萍和张贵云.2000.微生物农药研究进展.北京农业科学,18(4):22-24
张若飞.1987.奥妙的微生物科学出版社.
张新虎,何静and沈慧敏2008.苍耳提取物对番茄灰霉病菌的抑制作用及抑菌机理初探.草业学报,17(3):99-104
张妍,张建丽and牛宁昌2007.放线菌的分子分类.微生物学杂志,27(4):79-82
赵斌，何绍江2002.微生物学实验.北京：科学出版社202~203
中国科学院微生物研究所放线菌分类组1975.链霉菌鉴定手册.北京:科学出版社:13-15
周乐2000.有机化学实验,西安:世界图书出版社.
周南进,谢勇,谢正兴,龚燕锋,周小江,陈江and吕农华2004.壳聚糖对幽门螺杆菌形态及超微结构的影响.中华微生物学和免疫学杂志,11:009
朱宝泉,范少霞,张裕文和童村.1985.筛选新抗生素的一个新方法.中国医药工业杂志,8:
朱昌雄,谢德龄和倪楚芳.1990.农抗120防治西瓜枯萎病菌的室内药效实验.中国生物防治,3:008
朱春玉,吴元华和赵秀香.2006.嘧肽霉素抗烟草花叶病毒作用机理初步研究[J].植物病理学报,36(4):52-54
Aas J. A., Paster B. J., Stokes L. N., Olsen I. and Dewhirst F. E.2005. Defining the normal bacterialflora of the oral cavity. Journal of Clinical Microbiology,43(11):5721-5732
Adrio J. L., López M., Casqueiro J., Fernández C. and Veiga M.1995. Electrophoretic karyotype ofthe astaxanthin-producing yeast Phaffia rhodozyma. Current genetics,27(5):447-450
Agarkar S. and Gurav V.2004. Synthesis and antibacterial activity of2-aryl/heteryl-4-(2'-hydroxy-3'-chloro-5'-hydroxy methyl phenyl)-2,3-dihydro-1,5-benzothiazepines. INDIAN JOURNALOF HETEROCYCLIC CHEMISTRY,13(3):273-274
Ahn C. and Stiles M. E.1990. Plasmid-associated bacteriocin production by a strain ofCarnobacterium piscicola from meat. Applied and environmental microbiology,56(8):2503-2510
Amborabé B.-E., Fleurat-Lessard P., Chollet J.-F. and Roblin G.2002. Antifungal effects of salicylicacid and other benzoic acid derivatives towards Eutypa lata: structure–activity relationship. PlantPhysiology and Biochemistry,40(12):1051-1060
Ambrogi V., Furlani A., Grandolini G., Papaioannou A., Perioli L., Scarcia V. and Tuttobello L.1993.Synthesis, antimicrobial and cytostatic activities of some derivatives of indolo [2,3-b]-1,5-benzothiazepine, a novel heterocyclic ring system. European journal of medicinal chemistry,28(9):659-667
Ansari F. L., Iftikhar F., Mirza B., Baseer M. and Rashid U.2008. Solid-phase synthesis andbiological evaluation of a parallel library of2,3-dihydro-1,5-benzothiazepines. Bioorganic&medicinalchemistry,16(16):7691-7697
Ansari F. L., Umbreen S., Hussain L., Makhmoor T., Nawaz S. A., Lodhi M. A., Khan S. N., ShaheenF. and Choudhary M. I.2005. Syntheses and Biological Activities of Chalcone and1,5‐BenzothiazepineDerivatives: Promising New Free‐Radical Scavengers, and Esterase, Urease, and α‐GlucosidaseInhibitors. Chemistry&biodiversity,2(4):487-496
Archer G. A. and Sternbach L. H.1968. Chemistry of benzodiazepines. Chemical Reviews,68(6):747-784
Arya K. and Dandia A.2008. The expedient synthesis of1,5-benzothiazepines as a family ofcytotoxic drugs. Bioorganic&medicinal chemistry letters,18(1):114-119
Atwal K. S., Bergey J. L., Hedberg A. and Moreland S.1987. Synthesis and biological activity ofnovel calcium channel blockers:2,5-dihydro-4-methyl-2-phenyl-1,5-benzothiazepine-3-carboxylic acidesters and2,5-dihydro-4-methyl-2-phenyl-1,5-benzodiazepine-3-carboxylic acid esters. Journal ofmedicinal chemistry,30(4):635-640
Austin B. and Billaud A. C.1990. Inhibition of the fish pathogen, Serratia liquefaciens, by anantibiotic‐producing isolate of Planococcus recovered from sea water. Journal of Fish Diseases,13(6):553-556
Austin B., Stuckey L., Robertson P., Effendi I. and Griffith D.1995. A probiotic strain of Vibrioalginolyticus effective in reducing diseases caused by Aeromonas salmonicida, Vibrio anguillarum andVibrio ordalii. Journal of Fish Diseases,18(1):93-96
Bajaj K. and Kumar A.2004. Synthesis and pharmacological evaluation of newer substitutedbenzoxazepine derivatives as potent anticonvulsant agents. European journal of medicinal chemistry,39(4):369-376
Balakrishna M. and Kaboudin B.2001. A simple and new method for the synthesis of1,5-benzodiazepine derivatives on a solid surface. Tetrahedron Letters,42(6):1127-1129
Banic S. and Lunder M.1989. Additive effect of the combination of griseofulvin and ketoconazoleagainst Microsporum canis in vitro. Mycoses,32(9):487
Becker B. e. a.1964. Appl.Microbiol.12:421～423
Bedos P., Amblard M., Subra G., Dodey P., Luccarini J.-M., Paquet J.-L., Pruneau D., Aumelas A.and Martinez J.2000. A rational approach to the design and synthesis of a new bradykinin B1receptorantagonist. Journal of medicinal chemistry,43(12):2387-2394
Bennis S., Chami F., Chami N., Bouchikhi T. and Remmal A.2004. Surface alteration ofSaccharomyces cerevisiae induced by thymol and eugenol. Letters in Applied Microbiology,38(6):454-458
Berdy J.2005. Bioactive microbial metabolites. The Journal of antibiotics,58(1):1-26
Bogatskii A. and Andronati S. A.1970. The Present State of the Chemistry of1,4-Benzodiazepines.Russian Chemical Reviews,39(12):1064-1081
Bradford M. M.1976. A rapid and sensitive method for the quantitation of microgram quantities ofprotein utilizing the principle of protein-dye binding. Analytical biochemistry,72(1):248-254
Braun R. U., Zeitler K. and Müller T. J.2000. A Novel1,5-Benzoheteroazepine Synthesis via aOne-Pot Coupling-Isomerization-Cyclocondensation Sequence§. Organic letters,2(26):4181-4184
Broad C. D. and Cheney D. R.1971. Broad Critical Essays in Moral Philosophy. George Allen&Unwin
Buchanan R. E. e. a.1974. Bergey's Manual of Determinative Bacteriology(English Edition).
Buehlmayer P. and Furet P.1993. Substituted benzazepinones, WO Patent App. PCT/EP1993/003,425.
Calo P., Velazquez J. B., Sieiro C., Blanco P., Longo E. and Villa T. G.1995. Analysis of astaxanthinand other carotenoids from several Phaffia rhodozyma mutants. Journal of agricultural and food chemistry,43(5):1396-1399
Casas López J. L., Sánchez Pérez J. A., Fernández Sevilla J. M., Acién Fernández F. G., MolinaGrima E. and Chisti Y.2003. Production of lovastatin by Aspergillus terreus: effects of the C:N ratio andthe principal nutrients on growth and metabolite production. Enzyme and Microbial Technology,33(2–3):270-277
Chakravarti B., Siddiqui J. A., Dwivedi S. K. D., Deshpande S., Samanta K., Bhatta R. S., Panda G.,Prabhakar Y. S., Konwar R. and Sanyal S.2011. Specific targeting of insulin-like growth factor1receptorsignaling in human estrogen dependent breast cancer cell by a novel tyrosine-based benzoxazepinederivative. Molecular and cellular endocrinology,338(1):68-78
Chandrasekhar S., Seenaiah M., Kumar A., Reddy C. R., Mamidyala S. K., Kumar C. G. andBalasubramanian S.2011. Intramolecular copper (I)-catalyzed1,3-dipolar cycloaddition of azido-alkynes:synthesis of triazolo-benzoxazepine derivatives and their biological evaluation. Tetrahedron Letters,52(7):806-808
Chang Q., Liu H. and Chen J.1994. Extraction of lysozyme, α-chymotrypsin, and pepsin into reversemicelles formed using an anionic surfactant, isooctane, and water. Enzyme and microbial technology,16(11):970-973
Claremon D. A., Baldwin J. J., Liverton N. and Askew B.1998. Fibrinogen receptor antagonists,Google Patents.
Cocco M. T., Congiu C., Onnis V., Bernard A. M. and Piras P. P.1997. REACTION OFN1-ACYLACETAMIDRAZONES WITH TRIFLUOROACETYLVINYL ETHERS. SYNTHESIS OFNEW4-TRIFLUOROMETHYL-AND6-TRIFLUOROMETHYLPYRIDINES. Journal of heterocyclicchemistry,34(4):1283-1290
Colwell R.1970. Polyphasic taxonomy of the genus Vibrio: numerical taxonomy of Vibrio cholerae,Vibrio parahaemolyticus, and related Vibrio species. Journal of Bacteriology,104(1):410-433
Cook R. J.1993. Making greater use of introduced microorganisms for biological control of plantpathogens. Annual Review of Phytopathology,31(1):53-80
Crameri R. and Davies J.1986. Increased production of aminoglycosides associated with amplifiedantibiotic resistance genes. The Journal of antibiotics,39(1):128
Crowley L. V.1967. The Reitman–Frankel colorimetric transaminase procedure in suspectedmyocardial infarction. Clinical Chemistry,13:482-487
Dalevi D., Hugenholtz P. and Blackall L. L.2001. A multiple-outgroup approach to resolvingdivision-level phylogenetic relationships using16S rDNA data. International journal of systematic andevolutionary microbiology,51(2):385-391
Deng S. P. and Tabatabai M. A.1994. Colorimetric determination of reducing sugars in soils. SoilBiology and Biochemistry,26(4):473-477
Dhillon N., Hale R., Cortes J. and Leadlay P.1989. Molecular characterization of a gene fromSaccharopolyspora erythraea (Streptomyces erythraeus) which is involved in erythromycin biosynthesis.Molecular microbiology,3(10):1405-1414
Di Braccio M., Grossi G., Roma G., Vargiu L., Mura M. and Marongiu M. E.2001.1,5-Benzodiazepines. Part XII. Synthesis and biological evaluation of tricyclic and tetracyclic1,5-benzodiazepine derivatives as nevirapine analogues. European journal of medicinal chemistry,36(11):935-949
Di Santo R., Costi R., Artico M., Ragno R., Greco G., Novellino E., Marchand C. and Pommier Y.2005. Design, synthesis and biological evaluation of heteroaryl diketohexenoic and diketobutanoic acids asHIV-1integrase inhibitors endowed with antiretroviral activity. Il Farmaco,60(5):409-417
Donadio S. and Katz L.1992. Organization of the enzymatic domains in the multifunctionalpolyketide synthase involved in erythromycin formation in Saccharopolyspora erythraea. Gene,111(1):51-60
Donadio S., Staver M. J., McAlpine J. B., Swanson S. J. and Katz L.1991. Modular organization ofgenes required for complex polyketide biosynthesis. Science,252(5006):675-679
Endo A. and Misato T.1969. Polyoxin D, a competitive inhibitor of UDP-N-acetylglucosamine: chitinN-acetylglucosaminyltransferase in Neurospora crassa. Biochemical and biophysical researchcommunications,37(4):718-722
Essaber M., Baouid A., Hasnaoui A., Benharref A. and Lavergne J.-P.1998. Synthesis of new tri-andtetraheterocyclic systems:1,3-dipolar cycloaddition of nitrilimines on2,7-dimethyl-4-phenyl-3H-1,5-benzodiazepine. Synthetic communications,28(22):4097-4104
Feling R. H., Buchanan G. O., Mincer T. J., Kauffman C. A., Jensen P. R. and Fenical W.2003.Salinosporamide A: a highly cytotoxic proteasome inhibitor from a novel microbial source, a marinebacterium of the new genus Salinospora. Angewandte Chemie International Edition,42(3):355-357
Fiedler H.-P., Bruntner C., Bull A. T., Ward A. C., Goodfellow M., Potterat O., Puder C. and Mihm G.2005. Marine actinomycetes as a source of novel secondary metabolites. Antonie van Leeuwenhoek,87(1):37-42
Flam F.1994. Chemical prospectors scour the seas for promising drugs. Science,266(5189):1324-1325
Fodor L., Csomós P., Csámpai A. and Sohár P.2010. Staudinger and retro-Staudinger reactions. Thedichloro-β-lactam moiety as a useful handle for the synthesis of4-aryl-2H-1,3-benzothiazine1,1-dioxides.Tetrahedron Letters,51(24):3205-3207
Fujii N., Katsuyama T., Kobayashi E., Hara M. and Nakano H.1995. The clecarmycins, newantitumor antibiotics produced by Streptomyces: fermentation, isolation and biological properties. TheJournal of antibiotics,48(8):768
Fujita M N. K., Ito Y, et al1993. Biochem Biophys Res Commun.197(3):1340～1346
Gerth K., Washausen P., Hofle G., Irschik H. and Reichenbach H.1996. The jerangolids: A family ofnew antifungal compounds from Sorangium cellulosum (Myxobacteria). Production, physico-chemical andbiological properties of jerangolid A. The Journal of antibiotics,49(1):71
Halgren T. A.1999. MMFF VI. MMFF94s option for energy minimization studies. Journal ofComputational Chemistry,20(7):720-729
Hayakawa M., Momose Y., Kajiura T., Yamazaki T., Tamura T., Hatano K. and Nonomura H.1995.A selective isolation method for Actinomadura viridis in soil. Journal of fermentation and bioengineering,79(3):287-289
Henke B. R., Aquino C. J., Birkemo L. S., Croom D. K., Dougherty R. W., Ervin G. N., Grizzle M. K.,Hirst G. C., James M. K. and Johnson M. F.1997. Optimization of3-(1H-indazol-3-ylmethyl)-1,5-benzodiazepines as potent, orally active CCK-A agonists. Journal of medicinal chemistry,40(17):2706-2725
Higgins D. G., Bleasby A. J. and Fuchs R.1992. CLUSTAL V: improved software for multiplesequence alignment. Computer applications in the biosciences: CABIOS,8(2):189-191
Hood K. A. and Zarembski D. G.1997. Mycophenolate mofetil: a unique immunosuppressive agent.American journal of health-system pharmacy,54(3):285-294
Hopwood D. A.1999. Forty years of genetics with Streptomyces: from in vivo through in vitro to insilico. Microbiology,145(9):2183-2202
Hu H. and Ochi K.2001. Novel approach for improving the productivity of antibiotic-producingstrains by inducing combined resistant mutations. Applied and environmental microbiology,67(4):1885-1892
Ichikawa M., Yokomizo A., Itoh M., Sugita K., Usui H., Shimizu H., Suzuki M., Terayama K. andKanda A.2011. Discovery of a new2-aminobenzhydrol template for highly potent squalene synthaseinhibitors. Bioorganic&medicinal chemistry,19(6):1930-1949
Jensen P. R., Mincer T. J., Williams P. G. and Fenical W.2005. Marine actinomycete diversity andnatural product discovery. Antonie Van Leeuwenhoek,87(1):43-48
Jorgensen J. H., Crawford S. A., Kelly C. C. and Patterson J. E.2003. In vitro activity of daptomycinagainst vancomycin-resistant enterococci of various Van types and comparison of susceptibility testingmethods. Antimicrobial agents and chemotherapy,47(12):3760-3763
Jung D. I., Choi T. W., Kim Y. Y., Kim I. S., Park Y. M., Lee Y. G. and Jung D. H.1999. Synthesis of1,5‐Benzodiazepine Derivatives. ChemInform,30(32)
Kaboudin B. and Navaee K.2001. Alumina/phosphorus pentoxide (APP) as an efficient reagent forthe synthesis of1,5-benzodiazepines under microwave irradiation. Heterocycles,55(8):1443-1446
Kajiura T., Furumai T., Igarashi Y., HORI H., Higashi K., Ishiyama T., Uramoto M., Uehara Y. andOKI T.1998. Signal transduction inhibitors, hibarimicins A, B, C, D and G produced by Microbispora. I.Taxonomy, fermentation, isolation and physico-chemical and biological properties. Journal of antibiotics,51(4):394-401
Kaneko N.2005. Muscle relaxation accelerator and therapeutic agent for muscular tissue diseases suchas muscle relaxation failure, WO Patent2,005,105,793.
Knezovi S., unji V. and Lévai A.1993. Enantioselective hydrolysis of some3-(2-nitrophenoxy)butanoates catalyzed by Pseudomonas fluorescens and Pseudomonas sp. lipase. Tetrahedron: Asymmetry,4(3):313-320
Komaki H. and Harayama S.2006. Sequence diversity of type-II polyketide synthase genes inStreptomyces.日本放線菌学会誌,20(2):42-48
Kumar N., Singh G. and Yadav A. K.2001. Synthesis of some new pyrido [2,3‐d] pyrimidines andtheir ribofuranosides as possible antimicrobial agents. Heteroatom Chemistry,12(1):52-56
Kurtb ke D., Chen C. and Williams S.1992. Use of polyvalent phage for reduction of streptomyceteson soil dilution plates. Journal of Applied Microbiology,72(2):103-111
Lai Y.-S. and Stamper M.1995. Heteroatom effect in the PKC inhibitory activities of perhydroazepineanalogs of balanol. Bioorganic&Medicinal Chemistry Letters,5(18):2147-2150
Lambert R. J. W., Skandamis P. N., Coote P. J. and Nychas G. J. E.2001. A study of the minimuminhibitory concentration and mode of action of oregano essential oil, thymol and carvacrol. Journal ofApplied Microbiology,91(3):453-462
Larkin M., Blackshields G., Brown N., Chenna R., McGettigan P., McWilliam H., Valentin F.,Wallace I., Wilm A. and Lopez R.2007. Clustal W and Clustal X version2.0. Bioinformatics,23(21):2947-2948
Lazzarini A., Cavaletti L., Toppo G. and Marinelli F.2000. Rare genera of actinomycetes as potentialproducers of new antibiotics. Antonie van Leeuwenhoek,78(3-4):399-405
Lechevalier M. P. and Lechevalier H.1970. Chemical composition as a criterion in the classificationof aerobic actinomycetes. International Journal of Systematic Bacteriology,20(4):435-443
Lee E., Yu D., Martinez de Velasco J., Tessarollo L., Swing D. A., Jenkins N. A. and Copeland N. G.2001. A Highly Efficient Escherichia coli-Based Chromosome Engineering System Adapted forRecombinogenic Targeting and Subcloning of BAC DNA. Genomics,73(1):56-65
Lévai A.1997. Synthesis of pyrazolines by the reactions ofα, β-enones with diazomethane andhydrazines (review). Chemistry of Heterocyclic Compounds,33(6):647-659
Levai A., Toth G., Gondos T., JEK J. and Brahmbhatt D. I.2006. Reductive formation of1,5-benzothiazepines. Heterocycles,68(7):1319-1324
Li W.-J., Park D.-J., Tang S.-K., Wang D., Lee J.-C., Xu L.-H., Kim C.-J. and Jiang C.-L.2004.Nocardiopsis salina sp. nov., a novel halophilic actinomycete isolated from saline soil in China.International journal of systematic and evolutionary microbiology,54(5):1805-1809
Li Y. V., Terekhova L. and Gapochka M.2002. Isolation of actinomycetes from soil using extremelyhigh frequency radiation. Microbiology,71(1):105-108
Li Y. V., Terekhova L., Alferova I., Galatenko O. and Gapochka M.2003. The application ofsuccession analysis in combination with EHF irradiation to the selective isolation of actinomycetes fromsoil. Microbiology,72(1):114-117
Lin X., Hopson R. and Cane D. E.2006. Genome Mining in Streptomyces c oelicolor: MolecularCloning and Characterization of a New Sesquiterpene Synthase. Journal of the American Chemical Society,128(18):6022-6023
López-Cara L. C., Conejo-García A., Marchal J. A., Macchione G., Cruz-López O., Boulaiz H.,García M. A., Rodríguez-Serrano F., Ramírez A. and Cativiela C.2011. New (RS)-benzoxazepin-purineswith antitumour activity: The chiral switch from (RS)-2,6-dichloro-9-[1-(p-nitrobenzenesulfonyl)-1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl]-9H-purine. European journal of medicinal chemistry,46(1):249-258
Maeda M., Nogami K., Kanematsu S. and Kotani Y. Manipulation of Microbial Communities for theAquaculture Environment. Interactions Between Cultured Species and QV@py~~“r’r: y Ily OccurringSpecies the Environment:125
Magarvey N. A., Keller J. M., Bernan V., Dworkin M. and Sherman D. H.2004. Isolation andcharacterization of novel marine-derived actinomycete taxa rich in bioactive metabolites. Applied andenvironmental microbiology,70(12):7520-7529
Maldonado L. A., Fenical W., Jensen P. R., Kauffman C. A., Mincer T. J., Ward A. C., Bull A. T. andGoodfellow M.2005. Salinispora arenicola gen. nov., sp. nov. and Salinispora tropica sp. nov., obligatemarine actinomycetes belonging to the family Micromonosporaceae. International journal of systematicand evolutionary microbiology,55(5):1759-1766
Maruenda H. and Johnson F.1995. Design and synthesis of novel inhibitors of HIV-1reversetranscriptase. Journal of medicinal chemistry,38(12):2145-2151
Matsumoto Y., Tsuzuki R., Matsuhisa A., Yoden T., Yamagiwa Y., Yanagisawa I., Shibanuma T. andNohira H.2000. Novel potassium channel openers. Part4: transformation of the1,4-benzoxazine skeletoninto1,4-benzothiazine,1,2,3,4-tetrahydroquinoline,1,2,3,4-tetrahydroquinoxaline, indoline, and1,5-benzoxazepine. Bioorganic&medicinal chemistry,8(2):393-404
Mellouli L., Ben Ameur-Mehdi R., Sioud S., Salem M. and Bejar S.2003. Isolation, purification andpartial characterization of antibacterial activities produced by a newly isolated Streptomyces sp US24strain.Research in Microbiology,154(5):345-352
Meyer P., Du Preez J. and Kilian S.1993. Selection and evaluation of astaxanthin-overproducingmutants of Phaffia rhodozyma. World Journal of Microbiology and Biotechnology,9(5):514-520
Miki T., Kori M., Fujishima A., Mabuchi H., Tozawa R.-i., Nakamura M., Sugiyama Y. andYukimasa H.2002. Syntheses of fused heterocyclic compounds and their inhibitory activities for squalenesynthase. Bioorganic&medicinal chemistry,10(2):385-400
Miki T., Kori M., Mabuchi H., Tozawa R.-i., Nishimoto T., Sugiyama Y., Teshima K. and YukimasaH.2002. Synthesis of novel4,1-benzoxazepine derivatives as squalene synthase inhibitors and theirinhibition of cholesterol synthesis. Journal of medicinal chemistry,45(20):4571-4580
Momose I., Kinoshita N., Sawa R., Naganawa H., Iinuma H., Hamada M. and Takeuchi T.1998.Nothramicin, a new anthracycline antibiotic from Nocardia sp. MJ896-43F17. The Journal of antibiotics,51(2):130
Morales H. R., Bulbarela A. and Contreras R.1986. New synthesis of dihydro-and tetrahydro-1,5-benzodiazepines by reductive condensation of o-phenylenediamine and ketones in the presence ofsodium borohydride. Heterocycles,24(1):135-139
Muralidhar R., Chirumamila R., Marchant R. and Nigam P.2001. A response surface approach for thecomparison of lipase production by Candida cylindracea using two different carbon sources. BiochemicalEngineering Journal,9(1):17-23
Murata H., Suzuki K., Tabayashi T., Hattori C., Takada Y., Harada K.-i., Suzuki M., Ikemoto T.,Shibuya T. and Haneishi T.1995. Structural elucidation of aculeximycin. III. Planar structure ofaculeximycin, belonging to a new class of macrolide antibiotics. The Journal of antibiotics,48(8):838
Neochoritis C. G., Tsoleridis C. A., Stephanidou-Stephanatou J., Kontogiorgis C. A. andHadjipavlou-Litina D. J.2010.1,5-Benzoxazepines vs1,5-Benzodiazepines. One-PotMicrowave-Assisted Synthesis and Evaluation for Antioxidant Activity and Lipid Peroxidation Inhibition.Journal of medicinal chemistry,53(23):8409-8420
Nett M., Ikeda H. and Moore B. S.2009. Genomic basis for natural product biosynthetic diversity inthe actinomycetes. Natural product reports,26(11):1362-1384
NIE Y.-l., WANG C.-x., ZHENG Y.-b., LIN R., XU L.-y., Fei P., FANG D.-s., LIAN Y.-y. and JIANGH. Novel Secondary Metabolites with Cytotoxic Activities Produced by Verrucosispora sp. FIM06031fromMarine Sponge.
Ohemeng K. A., Schwender C. F., Fu K. P. and Barrett J. F.1993. DNA gyrase inhibitory andantibacterial activity of some flavones(1). Bioorganic&Medicinal Chemistry Letters,3(2):225-230
Pantev A., Valcheva R., Danova S., Ivanova I., Minkov I., Haertle T. and Chobert J.-M.2003. Effectof enterococcin A2000on biological and synthetic phospholipid membranes. International journal of foodmicrobiology,80(2):145-152
Patel P. and Desai K.2002. Synthesis of new heterocyclic thiazolidinone and azetidinone compoundsand their antibacterial activity. ORIENTAL JOURNAL OF CHEMISTRY,18(2):311-314
R B.1997. Outlook on agriculture.26(1):13～18
Rhayour K., Bouchikhi T., Tantaoui-Elaraki A., Sendide K. and Remmal A.2003. The mechanism ofbactericidal action of oregano and clove essential oils and of their phenolic major components onEscherichia coli and Bacillus subtilis. Journal of Essential Oil Research,15(4):286-292
Rico-Mora R., Voltolina D. and Villaescusa-Celaya J. A.1998. Biological control of Vibrioalginolyticus in Skeletonema costatum (Bacillariophyceae) cultures. Aquacultural Engineering,19(1):1-6
Rivera-Vargas L. I., Schmitthenner A. F. and Graham T. L.1993. Soybean flavonoid effects on andmetabolism by Phytophthora sojae. Phytochemistry,32(4):851-857
Roberts K., Ursini A., Barnaby R., Cassarà P. G., Corsi M., Curotto G., Donati D., Feriani A., FiniziaG. and Marchioro C.2011. Synthesis and structure–activity relationship of new1,5-dialkyl-1,5-benzodiazepines as cholecystokinin-2receptor antagonists. Bioorganic&medicinal chemistry,19(14):4257-4273
Robl J. A., Simpkins L. M., Stevenson J., Sun C.-Q., Murugesan N., Barrish J. C., Asaad M. M., BirdJ. E., Schaeffer T. R. and Trippodo N. C.1994. Dual metalloprotease inhibitors. I. Constrainedpeptidomimetics of mercaptoacyl dipeptides. Bioorganic&Medicinal Chemistry Letters,4(15):1789-1794
Saitou N. and Nei M.1987. The neighbor-joining method: a new method for reconstructingphylogenetic trees. Molecular biology and evolution,4(4):406-425
Sbrana C., Bagnoli G., Bedini S., Filippi C., Giovannetti M. and Nuti M.2000. Adhesion to hyphalmatrix and antifungal activity of Pseudomonas strains isolated from Tuber borchii ascocarps. Canadianjournal of microbiology,46(3):259-268
Schirmeister T.2000.(S)-Thiirancarboxylic acid as a reactive building block for a new class ofcysteine protease inhibitors. Bioorganic&medicinal chemistry letters,10(23):2647-2651
Shipkova P. A., Heimark L., Bartner P. L., Chen G., Pramanik B. N., Ganguly A. K., Cody R. B. andKusai A.2000. High‐resolution LC/MS for analysis of minor components in complex mixtures: negativeion ESI for identification of impurities and degradation products of a novel oligosaccharide antibiotic.Journal of mass spectrometry,35(11):1252-1258
Shirling E. t. and Gottlieb D.1966. Methods for characterization of Streptomyces species.International Journal of Systematic Bacteriology,16(3):313-340
standards N. c. f. c. l.2003. Methods for dilution antimicrobial susceptibility tests for bacteria thatgrow aerobically.
Sternbach L. and Reeder E.1961. Quinazolines and1,4-Benzodiazepines. IV.1,2Transformations of7-Chloro-2-methylamino-5-phenyl-3H-1,4-benzodiazepine4-Oxide3. The Journal of Organic Chemistry,26(12):4936-4941
Sternbach L. H.1971.1,4‐Benzodiazepines. Chemistry and Some Aspects of the Structure‐Activity Relationship. Angewandte Chemie International Edition in English,10(1):34-43
Sternbach L. H.1978. The benzodiazepine story. Springer
Sternbach L., Randall L., Banziger R. and Lehr H.1968. Structure-activity relationships in the1,4-benzodiazepine series. Drugs affecting the central nervous system,2:237-264
Sternbach L., Randall L., Gustafson S. and Gordon M.1964. Psychopharmacological agents. Acad.Press, New York:137-224
Strohl W. R.2004. Antimicrobials. Bull AT (ed) Microbial diversity and bioprospecting. ASM Press,Washington, DC:336-355
Tarabova B., Lacinova L. and Engel J.2007. Effects of phenylalkylamines and benzothiazepines onCa2+1.3-mediated Ca2+currents in neonatal mouse inner hair cells. European journal of pharmacology,573(1):39-48
Toki S., TANAKA T., UOSAKI Y., YOSHIDA M., SUZUKI Y., KITA K., MIHARA A., ANDO K.,LOKKER N. A. and GIESE N. A.1999. RP-1551s, a family of azaphilones produced by Penicillium sp.,inhibit the binding of PDGF to the extracellular domain of its receptor. Journal of antibiotics,52(3):235-244
Turgis M., Han J., Caillet S. and Lacroix M.2009. Antimicrobial activity of mustard essential oilagainst Escherichia coli O157:H7and Salmonella typhi. Food Control,20(12):1073-1079
Vandyck K., Cummings M. D., Nyanguile O. n., Boutton C. W., Vendeville S., McGowan D.,Devogelaere B., Amssoms K., Last S. and Rombauts K.2009. Structure-based design of a benzodiazepinescaffold yields a potent allosteric inhibitor of hepatitis C NS5B RNA polymerase. Journal of medicinalchemistry,52(14):4099-4102
Vara J., Lewandowska-Skarbek M., Wang Y.-G., Donadio S. and Hutchinson C.1989. Cloning ofgenes governing the deoxysugar portion of the erythromycin biosynthesis pathway in Saccharopolysporaerythraea (Streptomyces erythreus). Journal of bacteriology,171(11):5872-5881
Varala R., Enugala R., Nuvula S. and Adapa S. R.2006. Ceric ammonium nitrate (CAN) promotedefficient synthesis of1,5-benzodiazepine derivatives. Synlett,2006(07):1009-1014
Vichasilp C., Nakagawa K., Sookwong P., Suzuki Y., Kimura F., Higuchi O. and Miyazawa T.2009.Optimization of1-Deoxynojirimycin extraction from mulberry leaves by using response surfacemethodology. Bioscience, biotechnology, and biochemistry,73(12):2684-2689
Warr G. A., Veitch J. A., Walsh A. W., Hesler G. A., Pirnik D. M., Leet J. E., Lin P., Medina I. A.,McBrien K. D. and Forenza S.1996. BMS-182123, a fungal metabolite that inhibits the production ofTNF-alpha by macrophages and monocytes. The Journal of antibiotics,49(3):234-240
Yabuuchi E., Kosako Y., Yano I., Hotta H. and Nishiuchi Y.1994. Transfer of two Burkholderia andan Alcaligenes species to Ralstonia gen. nov.: Proposal of Ralstonia pickettii (Ralston, Palleroni andDoudoroff1973) comb. nov., Ralstonia solanacearum (Smith1896) comb. nov. and Ralstonia eutropha(Davis1969) comb. nov. Microbiology and immunology,39(11):897-904
Yadav J., Reddy B., Eshwaraiah B. and Anuradha K.2002. Amberlyst-15: a novel and recyclablereagent for the synthesis of1,5-benzodiazepines in ionic liquids. Green Chemistry,4(6):592-594
Yamamura H., Hayakawa M. and Iimura Y.2003. Application of sucrose‐gradient centrifugation forselective isolation of Nocardia spp. from soil. Journal of applied microbiology,95(4):677-685
Zengler K., Toledo G., Rappé M., Elkins J., Mathur E. J., Short J. M. and Keller M.2002. Cultivatingthe uncultured. Proceedings of the National Academy of Sciences,99(24):15681-15686
Zhang X. M. and Huang J. D.2003. Combination of overlapping bacterial artificial chromosomes by atwo‐step recombinogenic engineering method. Nucleic acids research,31(15): e81
Zhou X., Zhang M. Y., Gao S. T., Ma J. J., Wang C. and Liu C.2009. An efficient synthesis of1,5-benzodiazepine derivatives catalyzed by boric acid. Chinese Chemical Letters,20(8):905-908
Zificsak C. A., Theroff J. P., Aimone L. D., Albom M. S., Angeles T. S., Brown R. A., Galinis D.,Grobelny J. V., Herbertz T. and Husten J.2011.2,4-Diaminopyrimidine inhibitors of c-Met kinase bearingbenzoxazepine anilines. Bioorganic&medicinal chemistry letters,21(2):660-663
操庆国,郭钦,黄敏和刘爱兰.2006.天然抗菌物质研究进展.保鲜与加工,34(3):10
曹亚.2003.实用分子生物学操作指南人民卫生出版社.
陈义光,李文均,崔晓龙,姜成林,徐丽华,张玉琴和文孟良.2006.具抗肿瘤活性放线菌菌株YIM90022的分离和系统发育分析.微生物学报,46(5):696-701
冯爱娟和彭春雷.2003.抗菌物质的研究进展.荆门职业技术学院学报,18(3):92-96
盖婷婷,宋学呜,钱秀萍和赵凤生.2005.株抗万古霉素耐药菌的抗生素产生菌ARl148的鉴定.工业微生物,35(3)
顾觉奋.2005.膜分离技术在微生物制药中的应用.中国抗生素杂志,30(1):26-31
顾觉奋和魏爱琳.2002.大孔网状吸附剂在微生物制药分离纯化上的应用.离子交换与吸附,18(3):281-288
侯慧,徐汉虹,林壁润和查友贵.2003.防治植物病害的农用抗生素的研究及应用.河南农业科学,11:28-31
黄惠娟和乔建军.2007.聚酮类抗生素组合生物合成.细胞生物学杂志,29(5):692-696
黄丽丽,康振生,韩青梅,王兰和宗兆锋.三唑酮对玉米弯孢病菌超微结构和细胞化学的影响.
黄秀梨.2000.微生物学实验指导北京:高等教育出版社.62～64
姜怡,段淑蓉,唐蜀昆,陈华红,李文均和徐丽华.2006.稀有放线菌分离方法.微生物学通报,33(1):181-183
蒋细良和谢德龄.1997.中生菌素的抗生作用.植物病理学报,27(2):133-138
焦瑞身.2004.新世纪微生物学者的一项重要任务——未培养微生物的分离培养.生物工程学报,20(5):641-645
康振生.1996.植物病原真菌的超微结构北京:中国科学技术出版.
李成云.1997.生物农药的安全性评价.云南农业科技(4):44-46
李春香,董占能和张召术.2001.离子交换树脂在天然产物提取分离中的应用.云南化工,28(5):26-28
梁世中.1995.生物分离技术华南理工大学出版社.
林璧润和杨丽梅.1998.管碟法测定抗生素2507的技术条件探讨.广东农业科学(2):38-40
刘春琴,高智慧,曹宇和白钢.2007.链霉菌ZG0429的分类鉴定与链霉亲和素的分离纯化研究.微生物学报,47(01):7-10
刘飞和伍小丽.2006.获取新抗生素的途径研究.重庆中草药研究(2):37-40
刘国诠.2003.生物工程下游技术化学工业出版社现代生物技术与医药科技出版中心.
刘进兵,林崇懒,万一千和宋化灿.2008.1,5-苯并二氮杂(艹卓)的合成及其生物活性研究Synthesis and Bioactivities of1,5-Benzodiazepine Derivatives.有機化學,28(2):317-320
刘姝,陆兆新,吕凤霞,别小妹,房耀维和丁重阳.2007.株海洋放线菌的分类鉴定及抗菌活性研究.南京农业大学学报,30(4):124-129
刘志恒和姜成林.2004.放线菌现代生物学与生物技术科学出版社.
刘志俊,谢德明和刘治波.2000.国外农药发展现状及未来展望.农药科学与管理,21(2):33-37
罗曼,蒋立科,王志强,奚俊和戴建勇.2003.山苍籽油及主要成份抗菌机制研究进展.微生物学通报,30(3):74-77
吕洪久.1991.化学功能材料.化工新型材料,（8）：43
毛忠贵.1999.生物工业下游技术中国轻工业出版社.
慕立义.1994.植物化学保护研究方法.北京:中国农业出版社,102-104
聂亚锋,刘永锋,李德全,陈志谊,刘邮洲和罗楚平.2008.海洋细菌PY-sw-1产生的抗菌物质及其抑菌活性.植物保护学报,35(4):373-374
彭云霞,姜怡,段淑蓉,李文均和徐丽华.2007.稀有放线菌的选择性分离方法[J].云南大学学报:自然科学版,29(1):86-89
钱存柔和黄仪秀.2008.微生物学实验教程北京:北京大学出版社.
屈良.1993.微生物系统发育的分子遗传学研究概述上海:复旦大学出版社.
沈寅初.1981.国内外农用抗生素研究和发展概况.抗生素,6(3):55-64
沈寅初.1996.井冈霉素研究开发25年.植物保护,22(4):44-45
盛龙生.2003.药物分析化学工业出版社.
施跃峰.2000.微生物杀虫剂研究进展.植物保护,26(5):32-34
孙秋,杨慧敏,褚红标,李铭刚和文孟良.2003.筛选新抗生素的方法.云南农业科技,4:43-45
孙峋,汪靖超,李洪涛,杜桂彩和郭道森.2005.迷迭香酸的抗菌机理研究.青岛大学学报(自然科学版),18(4):41-45
孙宇辉和邓子新.2006.聚酮化合物及其组合生物合成
唐经凡.2008.抗生素的作用机理及应用.中国现代药物应用,2(7):99-100
唐韵.2003.农用抗生素十问.农药市场信息,10:061
瓦克斯曼和阎逊初.1974.放线菌:属和种的分类,鉴定和描述.第二卷科学出版社.
汪茂田,谢培山和王忠东.2004.天然有机化合物提取分离与结构鉴定化学工业出版社.
王福来.2001.有机化学实验武汉:武汉大学出版社.
王广成,张忠明,高立明,陈丙坤,聂果,万莉和吴春先.2006.阿维菌素的作用机理及其应用现状[J].植物医生,19(1):4-5
王琦和梅汝鸿.2001.我国生物农药的发展现状.中国微生态学杂志,13(3):177-178
王湛和周翀.2006.膜分离技术基础化学工业出版社.
吴文君.1988.植物化学保护实验技术导论西安:陕西科学技术出版社.134-135
吴文君.1988.植物化学保护实验技术指导西安:西安：陕西科学技术出版社.
徐汉虹和安玉兴.2001.生物农药的发展动态与趋势展望.农药科学与管理,22(1):32-34
徐丽华,李文均和刘志恒等.2007.放线菌系统学—原理、方法及实践北京:科学出版社.41-44
徐明生,陈锦屏和上官新晨.2005.鱼精蛋白对黑曲霉细胞内的琥珀酸脱氢酶和苹果酸脱氢酶的影响.食品科学,26(4):48-50
徐铮,曹永兵和姜远英.2001.麦角甾醇生物合成途径中的抗真菌药作用靶酶.国外医药:抗生素分册,22(5):193-197
姚健.2000.农用化学品污染对土壤微生物群落DNA序列多样性影响研究.20（6）
姚汝华.1996.微生物工程工艺原理华南理工大学出版社.
姚新生.2001.天然药物化学.
余卿.1987.新抗生素的筛选.微生物学杂志,1:28
俞俊棠,唐孝宣,生物工艺学和邬行彦.2003.新编生物工艺学化学工业出版社教材出版中心.
俞文和和杨纪根.1988.抗生素工艺学辽宁科学技术出版社.
张继忠1990.微生物学分类.上海：复旦大学出版社:144-146
张丽萍和张贵云.2000.微生物农药研究进展.北京农业科学,18(4):22-24
张若飞.1987.奥妙的微生物科学出版社.
张新虎,何静and沈慧敏2008.苍耳提取物对番茄灰霉病菌的抑制作用及抑菌机理初探.草业学报,17(3):99-104
张妍,张建丽and牛宁昌2007.放线菌的分子分类.微生物学杂志,27(4):79-82
赵斌，何绍江2002.微生物学实验.北京：科学出版社202~203
中国科学院微生物研究所放线菌分类组1975.链霉菌鉴定手册.北京:科学出版社:13-15
周乐2000.有机化学实验,西安:世界图书出版社.
周南进,谢勇,谢正兴,龚燕锋,周小江,陈江and吕农华2004.壳聚糖对幽门螺杆菌形态及超微结构的影响.中华微生物学和免疫学杂志,11:009
朱宝泉,范少霞,张裕文和童村.1985.筛选新抗生素的一个新方法.中国医药工业杂志,8:
朱昌雄,谢德龄和倪楚芳.1990.农抗120防治西瓜枯萎病菌的室内药效实验.中国生物防治,3:008
朱春玉,吴元华和赵秀香.2006.嘧肽霉素抗烟草花叶病毒作用机理初步研究[J].植物病理学报,36(4):52-54
Aas J. A., Paster B. J., Stokes L. N., Olsen I. and Dewhirst F. E.2005. Defining the normal bacterialflora of the oral cavity. Journal of Clinical Microbiology,43(11):5721-5732
Adrio J. L., López M., Casqueiro J., Fernández C. and Veiga M.1995. Electrophoretic karyotype ofthe astaxanthin-producing yeast Phaffia rhodozyma. Current genetics,27(5):447-450
Agarkar S. and Gurav V.2004. Synthesis and antibacterial activity of2-aryl/heteryl-4-(2'-hydroxy-3'-chloro-5'-hydroxy methyl phenyl)-2,3-dihydro-1,5-benzothiazepines. INDIAN JOURNALOF HETEROCYCLIC CHEMISTRY,13(3):273-274
Ahn C. and Stiles M. E.1990. Plasmid-associated bacteriocin production by a strain ofCarnobacterium piscicola from meat. Applied and environmental microbiology,56(8):2503-2510
Amborabé B.-E., Fleurat-Lessard P., Chollet J.-F. and Roblin G.2002. Antifungal effects of salicylicacid and other benzoic acid derivatives towards Eutypa lata: structure–activity relationship. PlantPhysiology and Biochemistry,40(12):1051-1060
Ambrogi V., Furlani A., Grandolini G., Papaioannou A., Perioli L., Scarcia V. and Tuttobello L.1993.Synthesis, antimicrobial and cytostatic activities of some derivatives of indolo [2,3-b]-1,5-benzothiazepine, a novel heterocyclic ring system. European journal of medicinal chemistry,28(9):659-667
Ansari F. L., Iftikhar F., Mirza B., Baseer M. and Rashid U.2008. Solid-phase synthesis andbiological evaluation of a parallel library of2,3-dihydro-1,5-benzothiazepines. Bioorganic&medicinalchemistry,16(16):7691-7697
Ansari F. L., Umbreen S., Hussain L., Makhmoor T., Nawaz S. A., Lodhi M. A., Khan S. N., ShaheenF. and Choudhary M. I.2005. Syntheses and Biological Activities of Chalcone and1,5‐BenzothiazepineDerivatives: Promising New Free‐Radical Scavengers, and Esterase, Urease, and α‐GlucosidaseInhibitors. Chemistry&biodiversity,2(4):487-496
Archer G. A. and Sternbach L. H.1968. Chemistry of benzodiazepines. Chemical Reviews,68(6):747-784
Arya K. and Dandia A.2008. The expedient synthesis of1,5-benzothiazepines as a family ofcytotoxic drugs. Bioorganic&medicinal chemistry letters,18(1):114-119
Atwal K. S., Bergey J. L., Hedberg A. and Moreland S.1987. Synthesis and biological activity ofnovel calcium channel blockers:2,5-dihydro-4-methyl-2-phenyl-1,5-benzothiazepine-3-carboxylic acidesters and2,5-dihydro-4-methyl-2-phenyl-1,5-benzodiazepine-3-carboxylic acid esters. Journal ofmedicinal chemistry,30(4):635-640
Austin B. and Billaud A. C.1990. Inhibition of the fish pathogen, Serratia liquefaciens, by anantibiotic‐producing isolate of Planococcus recovered from sea water. Journal of Fish Diseases,13(6):553-556
Austin B., Stuckey L., Robertson P., Effendi I. and Griffith D.1995. A probiotic strain of Vibrioalginolyticus effective in reducing diseases caused by Aeromonas salmonicida, Vibrio anguillarum andVibrio ordalii. Journal of Fish Diseases,18(1):93-96
Bajaj K. and Kumar A.2004. Synthesis and pharmacological evaluation of newer substitutedbenzoxazepine derivatives as potent anticonvulsant agents. European journal of medicinal chemistry,39(4):369-376
Balakrishna M. and Kaboudin B.2001. A simple and new method for the synthesis of1,5-benzodiazepine derivatives on a solid surface. Tetrahedron Letters,42(6):1127-1129
Banic S. and Lunder M.1989. Additive effect of the combination of griseofulvin and ketoconazoleagainst Microsporum canis in vitro. Mycoses,32(9):487
Becker B. e. a.1964. Appl.Microbiol.12:421～423
Bedos P., Amblard M., Subra G., Dodey P., Luccarini J.-M., Paquet J.-L., Pruneau D., Aumelas A.and Martinez J.2000. A rational approach to the design and synthesis of a new bradykinin B1receptorantagonist. Journal of medicinal chemistry,43(12):2387-2394
Bennis S., Chami F., Chami N., Bouchikhi T. and Remmal A.2004. Surface alteration ofSaccharomyces cerevisiae induced by thymol and eugenol. Letters in Applied Microbiology,38(6):454-458
Berdy J.2005. Bioactive microbial metabolites. The Journal of antibiotics,58(1):1-26
Bogatskii A. and Andronati S. A.1970. The Present State of the Chemistry of1,4-Benzodiazepines.Russian Chemical Reviews,39(12):1064-1081
Bradford M. M.1976. A rapid and sensitive method for the quantitation of microgram quantities ofprotein utilizing the principle of protein-dye binding. Analytical biochemistry,72(1):248-254
Braun R. U., Zeitler K. and Müller T. J.2000. A Novel1,5-Benzoheteroazepine Synthesis via aOne-Pot Coupling-Isomerization-Cyclocondensation Sequence§. Organic letters,2(26):4181-4184
Broad C. D. and Cheney D. R.1971. Broad Critical Essays in Moral Philosophy. George Allen&Unwin
Buchanan R. E. e. a.1974. Bergey's Manual of Determinative Bacteriology(English Edition).
Buehlmayer P. and Furet P.1993. Substituted benzazepinones, WO Patent App. PCT/EP1993/003,425.
Calo P., Velazquez J. B., Sieiro C., Blanco P., Longo E. and Villa T. G.1995. Analysis of astaxanthinand other carotenoids from several Phaffia rhodozyma mutants. Journal of agricultural and food chemistry,43(5):1396-1399
Casas López J. L., Sánchez Pérez J. A., Fernández Sevilla J. M., Acién Fernández F. G., MolinaGrima E. and Chisti Y.2003. Production of lovastatin by Aspergillus terreus: effects of the C:N ratio andthe principal nutrients on growth and metabolite production. Enzyme and Microbial Technology,33(2–3):270-277
Chakravarti B., Siddiqui J. A., Dwivedi S. K. D., Deshpande S., Samanta K., Bhatta R. S., Panda G.,Prabhakar Y. S., Konwar R. and Sanyal S.2011. Specific targeting of insulin-like growth factor1receptorsignaling in human estrogen dependent breast cancer cell by a novel tyrosine-based benzoxazepinederivative. Molecular and cellular endocrinology,338(1):68-78
Chandrasekhar S., Seenaiah M., Kumar A., Reddy C. R., Mamidyala S. K., Kumar C. G. andBalasubramanian S.2011. Intramolecular copper (I)-catalyzed1,3-dipolar cycloaddition of azido-alkynes:synthesis of triazolo-benzoxazepine derivatives and their biological evaluation. Tetrahedron Letters,52(7):806-808
Chang Q., Liu H. and Chen J.1994. Extraction of lysozyme, α-chymotrypsin, and pepsin into reversemicelles formed using an anionic surfactant, isooctane, and water. Enzyme and microbial technology,16(11):970-973
Claremon D. A., Baldwin J. J., Liverton N. and Askew B.1998. Fibrinogen receptor antagonists,Google Patents.
Cocco M. T., Congiu C., Onnis V., Bernard A. M. and Piras P. P.1997. REACTION OFN1-ACYLACETAMIDRAZONES WITH TRIFLUOROACETYLVINYL ETHERS. SYNTHESIS OFNEW4-TRIFLUOROMETHYL-AND6-TRIFLUOROMETHYLPYRIDINES. Journal of heterocyclicchemistry,34(4):1283-1290
Colwell R.1970. Polyphasic taxonomy of the genus Vibrio: numerical taxonomy of Vibrio cholerae,Vibrio parahaemolyticus, and related Vibrio species. Journal of Bacteriology,104(1):410-433
Cook R. J.1993. Making greater use of introduced microorganisms for biological control of plantpathogens. Annual Review of Phytopathology,31(1):53-80
Crameri R. and Davies J.1986. Increased production of aminoglycosides associated with amplifiedantibiotic resistance genes. The Journal of antibiotics,39(1):128
Crowley L. V.1967. The Reitman–Frankel colorimetric transaminase procedure in suspectedmyocardial infarction. Clinical Chemistry,13:482-487
Dalevi D., Hugenholtz P. and Blackall L. L.2001. A multiple-outgroup approach to resolvingdivision-level phylogenetic relationships using16S rDNA data. International journal of systematic andevolutionary microbiology,51(2):385-391
Deng S. P. and Tabatabai M. A.1994. Colorimetric determination of reducing sugars in soils. SoilBiology and Biochemistry,26(4):473-477
Dhillon N., Hale R., Cortes J. and Leadlay P.1989. Molecular characterization of a gene fromSaccharopolyspora erythraea (Streptomyces erythraeus) which is involved in erythromycin biosynthesis.Molecular microbiology,3(10):1405-1414
Di Braccio M., Grossi G., Roma G., Vargiu L., Mura M. and Marongiu M. E.2001.1,5-Benzodiazepines. Part XII. Synthesis and biological evaluation of tricyclic and tetracyclic1,5-benzodiazepine derivatives as nevirapine analogues. European journal of medicinal chemistry,36(11):935-949
Di Santo R., Costi R., Artico M., Ragno R., Greco G., Novellino E., Marchand C. and Pommier Y.2005. Design, synthesis and biological evaluation of heteroaryl diketohexenoic and diketobutanoic acids asHIV-1integrase inhibitors endowed with antiretroviral activity. Il Farmaco,60(5):409-417
Donadio S. and Katz L.1992. Organization of the enzymatic domains in the multifunctionalpolyketide synthase involved in erythromycin formation in Saccharopolyspora erythraea. Gene,111(1):51-60
Donadio S., Staver M. J., McAlpine J. B., Swanson S. J. and Katz L.1991. Modular organization ofgenes required for complex polyketide biosynthesis. Science,252(5006):675-679
Endo A. and Misato T.1969. Polyoxin D, a competitive inhibitor of UDP-N-acetylglucosamine: chitinN-acetylglucosaminyltransferase in Neurospora crassa. Biochemical and biophysical researchcommunications,37(4):718-722
Essaber M., Baouid A., Hasnaoui A., Benharref A. and Lavergne J.-P.1998. Synthesis of new tri-andtetraheterocyclic systems:1,3-dipolar cycloaddition of nitrilimines on2,7-dimethyl-4-phenyl-3H-1,5-benzodiazepine. Synthetic communications,28(22):4097-4104
Feling R. H., Buchanan G. O., Mincer T. J., Kauffman C. A., Jensen P. R. and Fenical W.2003.Salinosporamide A: a highly cytotoxic proteasome inhibitor from a novel microbial source, a marinebacterium of the new genus Salinospora. Angewandte Chemie International Edition,42(3):355-357
Fiedler H.-P., Bruntner C., Bull A. T., Ward A. C., Goodfellow M., Potterat O., Puder C. and Mihm G.2005. Marine actinomycetes as a source of novel secondary metabolites. Antonie van Leeuwenhoek,87(1):37-42
Flam F.1994. Chemical prospectors scour the seas for promising drugs. Science,266(5189):1324-1325
Fodor L., Csomós P., Csámpai A. and Sohár P.2010. Staudinger and retro-Staudinger reactions. Thedichloro-β-lactam moiety as a useful handle for the synthesis of4-aryl-2H-1,3-benzothiazine1,1-dioxides.Tetrahedron Letters,51(24):3205-3207
Fujii N., Katsuyama T., Kobayashi E., Hara M. and Nakano H.1995. The clecarmycins, newantitumor antibiotics produced by Streptomyces: fermentation, isolation and biological properties. TheJournal of antibiotics,48(8):768
Fujita M N. K., Ito Y, et al1993. Biochem Biophys Res Commun.197(3):1340～1346
Gerth K., Washausen P., Hofle G., Irschik H. and Reichenbach H.1996. The jerangolids: A family ofnew antifungal compounds from Sorangium cellulosum (Myxobacteria). Production, physico-chemical andbiological properties of jerangolid A. The Journal of antibiotics,49(1):71
Halgren T. A.1999. MMFF VI. MMFF94s option for energy minimization studies. Journal ofComputational Chemistry,20(7):720-729
Hayakawa M., Momose Y., Kajiura T., Yamazaki T., Tamura T., Hatano K. and Nonomura H.1995.A selective isolation method for Actinomadura viridis in soil. Journal of fermentation and bioengineering,79(3):287-289
Henke B. R., Aquino C. J., Birkemo L. S., Croom D. K., Dougherty R. W., Ervin G. N., Grizzle M. K.,Hirst G. C., James M. K. and Johnson M. F.1997. Optimization of3-(1H-indazol-3-ylmethyl)-1,5-benzodiazepines as potent, orally active CCK-A agonists. Journal of medicinal chemistry,40(17):2706-2725
Higgins D. G., Bleasby A. J. and Fuchs R.1992. CLUSTAL V: improved software for multiplesequence alignment. Computer applications in the biosciences: CABIOS,8(2):189-191
Hood K. A. and Zarembski D. G.1997. Mycophenolate mofetil: a unique immunosuppressive agent.American journal of health-system pharmacy,54(3):285-294
Hopwood D. A.1999. Forty years of genetics with Streptomyces: from in vivo through in vitro to insilico. Microbiology,145(9):2183-2202
Hu H. and Ochi K.2001. Novel approach for improving the productivity of antibiotic-producingstrains by inducing combined resistant mutations. Applied and environmental microbiology,67(4):1885-1892
Ichikawa M., Yokomizo A., Itoh M., Sugita K., Usui H., Shimizu H., Suzuki M., Terayama K. andKanda A.2011. Discovery of a new2-aminobenzhydrol template for highly potent squalene synthaseinhibitors. Bioorganic&medicinal chemistry,19(6):1930-1949
Jensen P. R., Mincer T. J., Williams P. G. and Fenical W.2005. Marine actinomycete diversity andnatural product discovery. Antonie Van Leeuwenhoek,87(1):43-48
Jorgensen J. H., Crawford S. A., Kelly C. C. and Patterson J. E.2003. In vitro activity of daptomycinagainst vancomycin-resistant enterococci of various Van types and comparison of susceptibility testingmethods. Antimicrobial agents and chemotherapy,47(12):3760-3763
Jung D. I., Choi T. W., Kim Y. Y., Kim I. S., Park Y. M., Lee Y. G. and Jung D. H.1999. Synthesis of1,5‐Benzodiazepine Derivatives. ChemInform,30(32)
Kaboudin B. and Navaee K.2001. Alumina/phosphorus pentoxide (APP) as an efficient reagent forthe synthesis of1,5-benzodiazepines under microwave irradiation. Heterocycles,55(8):1443-1446
Kajiura T., Furumai T., Igarashi Y., HORI H., Higashi K., Ishiyama T., Uramoto M., Uehara Y. andOKI T.1998. Signal transduction inhibitors, hibarimicins A, B, C, D and G produced by Microbispora. I.Taxonomy, fermentation, isolation and physico-chemical and biological properties. Journal of antibiotics,51(4):394-401
Kaneko N.2005. Muscle relaxation accelerator and therapeutic agent for muscular tissue diseases suchas muscle relaxation failure, WO Patent2,005,105,793.
Knezovi S., unji V. and Lévai A.1993. Enantioselective hydrolysis of some3-(2-nitrophenoxy)butanoates catalyzed by Pseudomonas fluorescens and Pseudomonas sp. lipase. Tetrahedron: Asymmetry,4(3):313-320
Komaki H. and Harayama S.2006. Sequence diversity of type-II polyketide synthase genes inStreptomyces.日本放線菌学会誌,20(2):42-48
Kumar N., Singh G. and Yadav A. K.2001. Synthesis of some new pyrido [2,3‐d] pyrimidines andtheir ribofuranosides as possible antimicrobial agents. Heteroatom Chemistry,12(1):52-56
Kurtb ke D., Chen C. and Williams S.1992. Use of polyvalent phage for reduction of streptomyceteson soil dilution plates. Journal of Applied Microbiology,72(2):103-111
Lai Y.-S. and Stamper M.1995. Heteroatom effect in the PKC inhibitory activities of perhydroazepineanalogs of balanol. Bioorganic&Medicinal Chemistry Letters,5(18):2147-2150
Lambert R. J. W., Skandamis P. N., Coote P. J. and Nychas G. J. E.2001. A study of the minimuminhibitory concentration and mode of action of oregano essential oil, thymol and carvacrol. Journal ofApplied Microbiology,91(3):453-462
Larkin M., Blackshields G., Brown N., Chenna R., McGettigan P., McWilliam H., Valentin F.,Wallace I., Wilm A. and Lopez R.2007. Clustal W and Clustal X version2.0. Bioinformatics,23(21):2947-2948
Lazzarini A., Cavaletti L., Toppo G. and Marinelli F.2000. Rare genera of actinomycetes as potentialproducers of new antibiotics. Antonie van Leeuwenhoek,78(3-4):399-405
Lechevalier M. P. and Lechevalier H.1970. Chemical composition as a criterion in the classificationof aerobic actinomycetes. International Journal of Systematic Bacteriology,20(4):435-443
Lee E., Yu D., Martinez de Velasco J., Tessarollo L., Swing D. A., Jenkins N. A. and Copeland N. G.2001. A Highly Efficient Escherichia coli-Based Chromosome Engineering System Adapted forRecombinogenic Targeting and Subcloning of BAC DNA. Genomics,73(1):56-65
Lévai A.1997. Synthesis of pyrazolines by the reactions ofα, β-enones with diazomethane andhydrazines (review). Chemistry of Heterocyclic Compounds,33(6):647-659
Levai A., Toth G., Gondos T., JEK J. and Brahmbhatt D. I.2006. Reductive formation of1,5-benzothiazepines. Heterocycles,68(7):1319-1324
Li W.-J., Park D.-J., Tang S.-K., Wang D., Lee J.-C., Xu L.-H., Kim C.-J. and Jiang C.-L.2004.Nocardiopsis salina sp. nov., a novel halophilic actinomycete isolated from saline soil in China.International journal of systematic and evolutionary microbiology,54(5):1805-1809
Li Y. V., Terekhova L. and Gapochka M.2002. Isolation of actinomycetes from soil using extremelyhigh frequency radiation. Microbiology,71(1):105-108
Li Y. V., Terekhova L., Alferova I., Galatenko O. and Gapochka M.2003. The application ofsuccession analysis in combination with EHF irradiation to the selective isolation of actinomycetes fromsoil. Microbiology,72(1):114-117
Lin X., Hopson R. and Cane D. E.2006. Genome Mining in Streptomyces c oelicolor: MolecularCloning and Characterization of a New Sesquiterpene Synthase. Journal of the American Chemical Society,128(18):6022-6023
López-Cara L. C., Conejo-García A., Marchal J. A., Macchione G., Cruz-López O., Boulaiz H.,García M. A., Rodríguez-Serrano F., Ramírez A. and Cativiela C.2011. New (RS)-benzoxazepin-purineswith antitumour activity: The chiral switch from (RS)-2,6-dichloro-9-[1-(p-nitrobenzenesulfonyl)-1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl]-9H-purine. European journal of medicinal chemistry,46(1):249-258
Maeda M., Nogami K., Kanematsu S. and Kotani Y. Manipulation of Microbial Communities for theAquaculture Environment. Interactions Between Cultured Species and QV@py~~“r’r: y Ily OccurringSpecies the Environment:125
Magarvey N. A., Keller J. M., Bernan V., Dworkin M. and Sherman D. H.2004. Isolation andcharacterization of novel marine-derived actinomycete taxa rich in bioactive metabolites. Applied andenvironmental microbiology,70(12):7520-7529
Maldonado L. A., Fenical W., Jensen P. R., Kauffman C. A., Mincer T. J., Ward A. C., Bull A. T. andGoodfellow M.2005. Salinispora arenicola gen. nov., sp. nov. and Salinispora tropica sp. nov., obligatemarine actinomycetes belonging to the family Micromonosporaceae. International journal of systematicand evolutionary microbiology,55(5):1759-1766
Maruenda H. and Johnson F.1995. Design and synthesis of novel inhibitors of HIV-1reversetranscriptase. Journal of medicinal chemistry,38(12):2145-2151
Matsumoto Y., Tsuzuki R., Matsuhisa A., Yoden T., Yamagiwa Y., Yanagisawa I., Shibanuma T. andNohira H.2000. Novel potassium channel openers. Part4: transformation of the1,4-benzoxazine skeletoninto1,4-benzothiazine,1,2,3,4-tetrahydroquinoline,1,2,3,4-tetrahydroquinoxaline, indoline, and1,5-benzoxazepine. Bioorganic&medicinal chemistry,8(2):393-404
Mellouli L., Ben Ameur-Mehdi R., Sioud S., Salem M. and Bejar S.2003. Isolation, purification andpartial characterization of antibacterial activities produced by a newly isolated Streptomyces sp US24strain.Research in Microbiology,154(5):345-352
Meyer P., Du Preez J. and Kilian S.1993. Selection and evaluation of astaxanthin-overproducingmutants of Phaffia rhodozyma. World Journal of Microbiology and Biotechnology,9(5):514-520
Miki T., Kori M., Fujishima A., Mabuchi H., Tozawa R.-i., Nakamura M., Sugiyama Y. andYukimasa H.2002. Syntheses of fused heterocyclic compounds and their inhibitory activities for squalenesynthase. Bioorganic&medicinal chemistry,10(2):385-400
Miki T., Kori M., Mabuchi H., Tozawa R.-i., Nishimoto T., Sugiyama Y., Teshima K. and YukimasaH.2002. Synthesis of novel4,1-benzoxazepine derivatives as squalene synthase inhibitors and theirinhibition of cholesterol synthesis. Journal of medicinal chemistry,45(20):4571-4580
Momose I., Kinoshita N., Sawa R., Naganawa H., Iinuma H., Hamada M. and Takeuchi T.1998.Nothramicin, a new anthracycline antibiotic from Nocardia sp. MJ896-43F17. The Journal of antibiotics,51(2):130
Morales H. R., Bulbarela A. and Contreras R.1986. New synthesis of dihydro-and tetrahydro-1,5-benzodiazepines by reductive condensation of o-phenylenediamine and ketones in the presence ofsodium borohydride. Heterocycles,24(1):135-139
Muralidhar R., Chirumamila R., Marchant R. and Nigam P.2001. A response surface approach for thecomparison of lipase production by Candida cylindracea using two different carbon sources. BiochemicalEngineering Journal,9(1):17-23
Murata H., Suzuki K., Tabayashi T., Hattori C., Takada Y., Harada K.-i., Suzuki M., Ikemoto T.,Shibuya T. and Haneishi T.1995. Structural elucidation of aculeximycin. III. Planar structure ofaculeximycin, belonging to a new class of macrolide antibiotics. The Journal of antibiotics,48(8):838
Neochoritis C. G., Tsoleridis C. A., Stephanidou-Stephanatou J., Kontogiorgis C. A. andHadjipavlou-Litina D. J.2010.1,5-Benzoxazepines vs1,5-Benzodiazepines. One-PotMicrowave-Assisted Synthesis and Evaluation for Antioxidant Activity and Lipid Peroxidation Inhibition.Journal of medicinal chemistry,53(23):8409-8420
Nett M., Ikeda H. and Moore B. S.2009. Genomic basis for natural product biosynthetic diversity inthe actinomycetes. Natural product reports,26(11):1362-1384
NIE Y.-l., WANG C.-x., ZHENG Y.-b., LIN R., XU L.-y., Fei P., FANG D.-s., LIAN Y.-y. and JIANGH. Novel Secondary Metabolites with Cytotoxic Activities Produced by Verrucosispora sp. FIM06031fromMarine Sponge.
Ohemeng K. A., Schwender C. F., Fu K. P. and Barrett J. F.1993. DNA gyrase inhibitory andantibacterial activity of some flavones(1). Bioorganic&Medicinal Chemistry Letters,3(2):225-230
Pantev A., Valcheva R., Danova S., Ivanova I., Minkov I., Haertle T. and Chobert J.-M.2003. Effectof enterococcin A2000on biological and synthetic phospholipid membranes. International journal of foodmicrobiology,80(2):145-152
Patel P. and Desai K.2002. Synthesis of new heterocyclic thiazolidinone and azetidinone compoundsand their antibacterial activity. ORIENTAL JOURNAL OF CHEMISTRY,18(2):311-314
R B.1997. Outlook on agriculture.26(1):13～18
Rhayour K., Bouchikhi T., Tantaoui-Elaraki A., Sendide K. and Remmal A.2003. The mechanism ofbactericidal action of oregano and clove essential oils and of their phenolic major components onEscherichia coli and Bacillus subtilis. Journal of Essential Oil Research,15(4):286-292
Rico-Mora R., Voltolina D. and Villaescusa-Celaya J. A.1998. Biological control of Vibrioalginolyticus in Skeletonema costatum (Bacillariophyceae) cultures. Aquacultural Engineering,19(1):1-6
Rivera-Vargas L. I., Schmitthenner A. F. and Graham T. L.1993. Soybean flavonoid effects on andmetabolism by Phytophthora sojae. Phytochemistry,32(4):851-857
Roberts K., Ursini A., Barnaby R., Cassarà P. G., Corsi M., Curotto G., Donati D., Feriani A., FiniziaG. and Marchioro C.2011. Synthesis and structure–activity relationship of new1,5-dialkyl-1,5-benzodiazepines as cholecystokinin-2receptor antagonists. Bioorganic&medicinal chemistry,19(14):4257-4273
Robl J. A., Simpkins L. M., Stevenson J., Sun C.-Q., Murugesan N., Barrish J. C., Asaad M. M., BirdJ. E., Schaeffer T. R. and Trippodo N. C.1994. Dual metalloprotease inhibitors. I. Constrainedpeptidomimetics of mercaptoacyl dipeptides. Bioorganic&Medicinal Chemistry Letters,4(15):1789-1794
Saitou N. and Nei M.1987. The neighbor-joining method: a new method for reconstructingphylogenetic trees. Molecular biology and evolution,4(4):406-425
Sbrana C., Bagnoli G., Bedini S., Filippi C., Giovannetti M. and Nuti M.2000. Adhesion to hyphalmatrix and antifungal activity of Pseudomonas strains isolated from Tuber borchii ascocarps. Canadianjournal of microbiology,46(3):259-268
Schirmeister T.2000.(S)-Thiirancarboxylic acid as a reactive building block for a new class ofcysteine protease inhibitors. Bioorganic&medicinal chemistry letters,10(23):2647-2651
Shipkova P. A., Heimark L., Bartner P. L., Chen G., Pramanik B. N., Ganguly A. K., Cody R. B. andKusai A.2000. High‐resolution LC/MS for analysis of minor components in complex mixtures: negativeion ESI for identification of impurities and degradation products of a novel oligosaccharide antibiotic.Journal of mass spectrometry,35(11):1252-1258
Shirling E. t. and Gottlieb D.1966. Methods for characterization of Streptomyces species.International Journal of Systematic Bacteriology,16(3):313-340
standards N. c. f. c. l.2003. Methods for dilution antimicrobial susceptibility tests for bacteria thatgrow aerobically.
Sternbach L. and Reeder E.1961. Quinazolines and1,4-Benzodiazepines. IV.1,2Transformations of7-Chloro-2-methylamino-5-phenyl-3H-1,4-benzodiazepine4-Oxide3. The Journal of Organic Chemistry,26(12):4936-4941
Sternbach L. H.1971.1,4‐Benzodiazepines. Chemistry and Some Aspects of the Structure‐Activity Relationship. Angewandte Chemie International Edition in English,10(1):34-43
Sternbach L. H.1978. The benzodiazepine story. Springer
Sternbach L., Randall L., Banziger R. and Lehr H.1968. Structure-activity relationships in the1,4-benzodiazepine series. Drugs affecting the central nervous system,2:237-264
Sternbach L., Randall L., Gustafson S. and Gordon M.1964. Psychopharmacological agents. Acad.Press, New York:137-224
Strohl W. R.2004. Antimicrobials. Bull AT (ed) Microbial diversity and bioprospecting. ASM Press,Washington, DC:336-355
Tarabova B., Lacinova L. and Engel J.2007. Effects of phenylalkylamines and benzothiazepines onCa2+1.3-mediated Ca2+currents in neonatal mouse inner hair cells. European journal of pharmacology,573(1):39-48
Toki S., TANAKA T., UOSAKI Y., YOSHIDA M., SUZUKI Y., KITA K., MIHARA A., ANDO K.,LOKKER N. A. and GIESE N. A.1999. RP-1551s, a family of azaphilones produced by Penicillium sp.,inhibit the binding of PDGF to the extracellular domain of its receptor. Journal of antibiotics,52(3):235-244
Turgis M., Han J., Caillet S. and Lacroix M.2009. Antimicrobial activity of mustard essential oilagainst Escherichia coli O157:H7and Salmonella typhi. Food Control,20(12):1073-1079
Vandyck K., Cummings M. D., Nyanguile O. n., Boutton C. W., Vendeville S., McGowan D.,Devogelaere B., Amssoms K., Last S. and Rombauts K.2009. Structure-based design of a benzodiazepinescaffold yields a potent allosteric inhibitor of hepatitis C NS5B RNA polymerase. Journal of medicinalchemistry,52(14):4099-4102
Vara J., Lewandowska-Skarbek M., Wang Y.-G., Donadio S. and Hutchinson C.1989. Cloning ofgenes governing the deoxysugar portion of the erythromycin biosynthesis pathway in Saccharopolysporaerythraea (Streptomyces erythreus). Journal of bacteriology,171(11):5872-5881
Varala R., Enugala R., Nuvula S. and Adapa S. R.2006. Ceric ammonium nitrate (CAN) promotedefficient synthesis of1,5-benzodiazepine derivatives. Synlett,2006(07):1009-1014
Vichasilp C., Nakagawa K., Sookwong P., Suzuki Y., Kimura F., Higuchi O. and Miyazawa T.2009.Optimization of1-Deoxynojirimycin extraction from mulberry leaves by using response surfacemethodology. Bioscience, biotechnology, and biochemistry,73(12):2684-2689
Warr G. A., Veitch J. A., Walsh A. W., Hesler G. A., Pirnik D. M., Leet J. E., Lin P., Medina I. A.,McBrien K. D. and Forenza S.1996. BMS-182123, a fungal metabolite that inhibits the production ofTNF-alpha by macrophages and monocytes. The Journal of antibiotics,49(3):234-240
Yabuuchi E., Kosako Y., Yano I., Hotta H. and Nishiuchi Y.1994. Transfer of two Burkholderia andan Alcaligenes species to Ralstonia gen. nov.: Proposal of Ralstonia pickettii (Ralston, Palleroni andDoudoroff1973) comb. nov., Ralstonia solanacearum (Smith1896) comb. nov. and Ralstonia eutropha(Davis1969) comb. nov. Microbiology and immunology,39(11):897-904
Yadav J., Reddy B., Eshwaraiah B. and Anuradha K.2002. Amberlyst-15: a novel and recyclablereagent for the synthesis of1,5-benzodiazepines in ionic liquids. Green Chemistry,4(6):592-594
Yamamura H., Hayakawa M. and Iimura Y.2003. Application of sucrose‐gradient centrifugation forselective isolation of Nocardia spp. from soil. Journal of applied microbiology,95(4):677-685
Zengler K., Toledo G., Rappé M., Elkins J., Mathur E. J., Short J. M. and Keller M.2002. Cultivatingthe uncultured. Proceedings of the National Academy of Sciences,99(24):15681-15686
Zhang X. M. and Huang J. D.2003. Combination of overlapping bacterial artificial chromosomes by atwo‐step recombinogenic engineering method. Nucleic acids research,31(15): e81
Zhou X., Zhang M. Y., Gao S. T., Ma J. J., Wang C. and Liu C.2009. An efficient synthesis of1,5-benzodiazepine derivatives catalyzed by boric acid. Chinese Chemical Letters,20(8):905-908
Zificsak C. A., Theroff J. P., Aimone L. D., Albom M. S., Angeles T. S., Brown R. A., Galinis D.,Grobelny J. V., Herbertz T. and Husten J.2011.2,4-Diaminopyrimidine inhibitors of c-Met kinase bearingbenzoxazepine anilines. Bioorganic&medicinal chemistry letters,21(2):660-663
© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号 地址：北京市海淀区学院路29号 邮编：100083 电话：办公室：(+86 10)66554848；文献借阅、咨询服务、科技查新：66554700 |